CA2321025A1 - Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors - Google Patents
Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors Download PDFInfo
- Publication number
- CA2321025A1 CA2321025A1 CA002321025A CA2321025A CA2321025A1 CA 2321025 A1 CA2321025 A1 CA 2321025A1 CA 002321025 A CA002321025 A CA 002321025A CA 2321025 A CA2321025 A CA 2321025A CA 2321025 A1 CA2321025 A1 CA 2321025A1
- Authority
- CA
- Canada
- Prior art keywords
- carboxamidine
- thiazol
- methylthiothiophene
- alkyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Heteroaryl amidines Chemical class 0.000 title claims description 455
- 239000002797 plasminogen activator inhibitor Substances 0.000 title description 9
- 150000002357 guanidines Chemical class 0.000 title description 7
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 161
- 238000000034 method Methods 0.000 claims abstract description 50
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 35
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 27
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 24
- 102000035195 Peptidases Human genes 0.000 claims abstract description 20
- 108091005804 Peptidases Proteins 0.000 claims abstract description 20
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims abstract description 20
- 229960005356 urokinase Drugs 0.000 claims abstract description 20
- 108010088842 Fibrinolysin Proteins 0.000 claims abstract description 15
- 229940012957 plasmin Drugs 0.000 claims abstract description 15
- 239000004365 Protease Substances 0.000 claims abstract description 13
- 239000012453 solvate Substances 0.000 claims abstract description 10
- 108090000317 Chymotrypsin Proteins 0.000 claims abstract description 9
- 229960002376 chymotrypsin Drugs 0.000 claims abstract description 9
- 108090000631 Trypsin Proteins 0.000 claims abstract description 7
- 102000004142 Trypsin Human genes 0.000 claims abstract description 7
- 239000012588 trypsin Substances 0.000 claims abstract description 7
- 229960001322 trypsin Drugs 0.000 claims abstract description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 209
- 125000000217 alkyl group Chemical group 0.000 claims description 109
- 239000001257 hydrogen Substances 0.000 claims description 79
- 229910052739 hydrogen Inorganic materials 0.000 claims description 79
- 239000007787 solid Substances 0.000 claims description 66
- 238000011282 treatment Methods 0.000 claims description 59
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 57
- 125000003118 aryl group Chemical group 0.000 claims description 56
- 238000010992 reflux Methods 0.000 claims description 56
- 125000003545 alkoxy group Chemical group 0.000 claims description 55
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 54
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 51
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 49
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 48
- 150000002431 hydrogen Chemical group 0.000 claims description 47
- 229910052736 halogen Inorganic materials 0.000 claims description 42
- 150000002367 halogens Chemical group 0.000 claims description 42
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 34
- 125000004414 alkyl thio group Chemical group 0.000 claims description 32
- 125000004104 aryloxy group Chemical group 0.000 claims description 27
- 125000000623 heterocyclic group Chemical group 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 27
- 235000019270 ammonium chloride Nutrition 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 25
- 125000005110 aryl thio group Chemical group 0.000 claims description 25
- 150000002148 esters Chemical class 0.000 claims description 24
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 claims description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 23
- 125000003282 alkyl amino group Chemical group 0.000 claims description 23
- 239000000725 suspension Substances 0.000 claims description 23
- 125000004442 acylamino group Chemical group 0.000 claims description 22
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- 125000000335 thiazolyl group Chemical group 0.000 claims description 21
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 20
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims description 20
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 20
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 claims description 19
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 19
- 125000001424 substituent group Chemical group 0.000 claims description 19
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 18
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims description 18
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 18
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 17
- 125000002971 oxazolyl group Chemical group 0.000 claims description 17
- 239000011593 sulfur Chemical group 0.000 claims description 17
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims description 16
- 125000001544 thienyl group Chemical group 0.000 claims description 16
- 206010028980 Neoplasm Diseases 0.000 claims description 15
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 15
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 125000004076 pyridyl group Chemical group 0.000 claims description 15
- 125000005140 aralkylsulfonyl group Chemical group 0.000 claims description 13
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 13
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000002883 imidazolyl group Chemical group 0.000 claims description 12
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims description 10
- 125000005202 dialkylaminocarbonyloxy group Chemical group 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 10
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims description 10
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 claims description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 108090000617 Cathepsin G Proteins 0.000 claims description 9
- 239000002841 Lewis acid Substances 0.000 claims description 9
- 206010027476 Metastases Diseases 0.000 claims description 9
- 108090000190 Thrombin Proteins 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 9
- 150000007517 lewis acids Chemical class 0.000 claims description 9
- 230000009401 metastasis Effects 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 8
- 206010060862 Prostate cancer Diseases 0.000 claims description 8
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 8
- 201000004681 Psoriasis Diseases 0.000 claims description 8
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 claims description 8
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 8
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims description 8
- 125000004671 dialkylaminothiocarbonyl group Chemical group 0.000 claims description 8
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 210000000265 leukocyte Anatomy 0.000 claims description 8
- 229960004072 thrombin Drugs 0.000 claims description 8
- OMMIMDGHTTXEFT-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(Cl)=CC=2)=C1SC OMMIMDGHTTXEFT-UHFFFAOYSA-N 0.000 claims description 7
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 7
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 7
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 7
- 239000012298 atmosphere Substances 0.000 claims description 7
- 125000002541 furyl group Chemical group 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 7
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 7
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 7
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 7
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 7
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 7
- 206010014561 Emphysema Diseases 0.000 claims description 6
- 108010074860 Factor Xa Proteins 0.000 claims description 6
- 125000004670 alkyl amino thio carbonyl group Chemical group 0.000 claims description 6
- 125000001769 aryl amino group Chemical group 0.000 claims description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 6
- 125000001624 naphthyl group Chemical group 0.000 claims description 6
- 125000005968 oxazolinyl group Chemical group 0.000 claims description 6
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 6
- 208000037803 restenosis Diseases 0.000 claims description 6
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims description 6
- 102100033174 Neutrophil elastase Human genes 0.000 claims description 5
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 5
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 5
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 claims description 5
- 125000002769 thiazolinyl group Chemical group 0.000 claims description 5
- 125000003441 thioacyl group Chemical group 0.000 claims description 5
- HNTSNHYPGXXIFN-UHFFFAOYSA-N 4-[2-(2,3-dichloroanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=C(Cl)C=CC=3)Cl)SC=2)=C1SC HNTSNHYPGXXIFN-UHFFFAOYSA-N 0.000 claims description 4
- AEBZRNXDNPAWQV-UHFFFAOYSA-N 4-[2-(2-bromoanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=CC=3)Br)SC=2)=C1SC AEBZRNXDNPAWQV-UHFFFAOYSA-N 0.000 claims description 4
- ZUWAYNCFFNVIBJ-UHFFFAOYSA-N 4-[2-(2-fluoroanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=CC=3)F)SC=2)=C1SC ZUWAYNCFFNVIBJ-UHFFFAOYSA-N 0.000 claims description 4
- LIRPGSNQMOFUBQ-UHFFFAOYSA-N 4-[2-(3-chloro-2-methylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=C(Cl)C=CC=3)C)SC=2)=C1SC LIRPGSNQMOFUBQ-UHFFFAOYSA-N 0.000 claims description 4
- QJRTVZFPEDJWOS-UHFFFAOYSA-N 4-[2-(4-methoxyanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound C1=CC(OC)=CC=C1NC1=NC(C2=C(SC(=C2)C(N)=N)SC)=CS1 QJRTVZFPEDJWOS-UHFFFAOYSA-N 0.000 claims description 4
- ABEISAYFSWNEFB-UHFFFAOYSA-N 4-[2-(benzhydrylamino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC(C=3C=CC=CC=3)C=3C=CC=CC=3)SC=2)=C1SC ABEISAYFSWNEFB-UHFFFAOYSA-N 0.000 claims description 4
- FJPXRXLMSZWSFX-UHFFFAOYSA-N 4-[2-[4-(dimethylamino)anilino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(=CC=3)N(C)C)SC=2)=C1SC FJPXRXLMSZWSFX-UHFFFAOYSA-N 0.000 claims description 4
- KLVFDMVKNCAXRG-UHFFFAOYSA-N 4-[4-(3-hydroxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(O)C=CC=2)=C1SC KLVFDMVKNCAXRG-UHFFFAOYSA-N 0.000 claims description 4
- UZGWXXYKZGJHJY-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-methyl-1,3-thiazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(C)N=2)=C1SC UZGWXXYKZGJHJY-UHFFFAOYSA-N 0.000 claims description 4
- HZNLMAXGKJQXSL-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-phenyl-1,3-thiazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC=CC=2)=C1SC HZNLMAXGKJQXSL-UHFFFAOYSA-N 0.000 claims description 4
- YCMAPLMAEQZHAF-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(2,4,5-trimethylanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC(C)=C(C)C=3)C)SC=2)=C1SC YCMAPLMAEQZHAF-UHFFFAOYSA-N 0.000 claims description 4
- VCMYKMXIDILKGK-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(3,4,5-trimethoxyanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC=C(N=2)C2=C(SC(=C2)C(N)=N)SC)=C1 VCMYKMXIDILKGK-UHFFFAOYSA-N 0.000 claims description 4
- NPTFSUUZGYDTPV-UHFFFAOYSA-N 5-methylsulfanyl-4-phenylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2C=CC=CC=2)=C1SC NPTFSUUZGYDTPV-UHFFFAOYSA-N 0.000 claims description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 201000005569 Gout Diseases 0.000 claims description 4
- 108010028275 Leukocyte Elastase Proteins 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000006598 aminocarbonylamino group Chemical group 0.000 claims description 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 125000004986 diarylamino group Chemical group 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 125000002636 imidazolinyl group Chemical group 0.000 claims description 4
- 125000002757 morpholinyl group Chemical group 0.000 claims description 4
- 125000006501 nitrophenyl group Chemical group 0.000 claims description 4
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
- 125000003107 substituted aryl group Chemical group 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- KAKQVSNHTBLJCH-UHFFFAOYSA-N trifluoromethanesulfonimidic acid Chemical compound NS(=O)(=O)C(F)(F)F KAKQVSNHTBLJCH-UHFFFAOYSA-N 0.000 claims description 4
- GFTDFOYLMGQHFH-UHFFFAOYSA-N 4-(4-cyclohexyl-1,3-thiazol-2-yl)-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C2CCCCC2)=C1SC GFTDFOYLMGQHFH-UHFFFAOYSA-N 0.000 claims description 3
- BBZQWPQSGQXDJT-UHFFFAOYSA-N 4-[2-(2-bromo-4-methylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC(C)=CC=3)Br)SC=2)=C1SC BBZQWPQSGQXDJT-UHFFFAOYSA-N 0.000 claims description 3
- WHGZPVSQCGFYBQ-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)=C1SC WHGZPVSQCGFYBQ-UHFFFAOYSA-N 0.000 claims description 3
- YNLXACABVDXVBV-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(2-propan-2-ylanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=CC=3)C(C)C)SC=2)=C1SC YNLXACABVDXVBV-UHFFFAOYSA-N 0.000 claims description 3
- WWYYVQSACHTSIU-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(3-phenylpropylamino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NCCCC=3C=CC=CC=3)SC=2)=C1SC WWYYVQSACHTSIU-UHFFFAOYSA-N 0.000 claims description 3
- WIMAUEHWGLTHAB-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(4-phenylmethoxyanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(OCC=4C=CC=CC=4)=CC=3)SC=2)=C1SC WIMAUEHWGLTHAB-UHFFFAOYSA-N 0.000 claims description 3
- IHVADESBZZCEJN-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1SC IHVADESBZZCEJN-UHFFFAOYSA-N 0.000 claims description 3
- AIGVJMZDTQIJIQ-UHFFFAOYSA-N 5-methylsulfanyl-4-propan-2-ylsulfonylthiophene-2-carboximidamide Chemical compound CSC=1SC(C(N)=N)=CC=1S(=O)(=O)C(C)C AIGVJMZDTQIJIQ-UHFFFAOYSA-N 0.000 claims description 3
- 108090000107 Acrosin Proteins 0.000 claims description 3
- 102100026041 Acrosin Human genes 0.000 claims description 3
- 108010028774 Complement C1 Proteins 0.000 claims description 3
- 102000016917 Complement C1 Human genes 0.000 claims description 3
- 108010067641 Complement C3-C5 Convertases Proteins 0.000 claims description 3
- 102000016574 Complement C3-C5 Convertases Human genes 0.000 claims description 3
- 108060005987 Kallikrein Proteins 0.000 claims description 3
- 102000001399 Kallikrein Human genes 0.000 claims description 3
- 206010033645 Pancreatitis Diseases 0.000 claims description 3
- 125000003368 amide group Chemical group 0.000 claims description 3
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims description 3
- 125000003971 isoxazolinyl group Chemical group 0.000 claims description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 3
- 125000004193 piperazinyl group Chemical group 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 3
- 125000001422 pyrrolinyl group Chemical group 0.000 claims description 3
- 229940124530 sulfonamide Drugs 0.000 claims description 3
- 150000003456 sulfonamides Chemical class 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- KUJMRNQABKKTCS-UHFFFAOYSA-N 2-[4-[[4-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-2-yl]amino]phenoxy]acetamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(OCC(N)=O)=CC=3)SC=2)=C1SC KUJMRNQABKKTCS-UHFFFAOYSA-N 0.000 claims description 2
- BOBLTMKWXURBGT-UHFFFAOYSA-N 4-(2-anilino-1,3-thiazol-4-yl)-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC=CC=3)SC=2)=C1SC BOBLTMKWXURBGT-UHFFFAOYSA-N 0.000 claims description 2
- IXGGMKCHAZTPHZ-UHFFFAOYSA-N 4-(2-anilino-1,3-thiazol-4-yl)-5-methylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC=CC=3)SC=2)=C1C IXGGMKCHAZTPHZ-UHFFFAOYSA-N 0.000 claims description 2
- NPCBXIKUSHWJQE-UHFFFAOYSA-N 4-(4-benzyl-1,3-thiazol-2-yl)-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(CC=3C=CC=CC=3)N=2)=C1SC NPCBXIKUSHWJQE-UHFFFAOYSA-N 0.000 claims description 2
- HVQOQBTUGXWDDB-UHFFFAOYSA-N 4-(5-methyl-4-phenyl-1,3-thiazol-2-yl)-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC(C)=C(N=2)C=2C=CC=CC=2)=C1SC HVQOQBTUGXWDDB-UHFFFAOYSA-N 0.000 claims description 2
- BXNZUFPOZGUYCZ-UHFFFAOYSA-N 4-[2-(2-chloroanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=CC=3)Cl)SC=2)=C1SC BXNZUFPOZGUYCZ-UHFFFAOYSA-N 0.000 claims description 2
- HGIXJHOCGNJKND-UHFFFAOYSA-N 4-[2-(3-hydroxyanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C(O)C=CC=3)SC=2)=C1SC HGIXJHOCGNJKND-UHFFFAOYSA-N 0.000 claims description 2
- LRFAHFBYANUWOO-UHFFFAOYSA-N 4-[2-(4-anilinoanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(NC=4C=CC=CC=4)=CC=3)SC=2)=C1SC LRFAHFBYANUWOO-UHFFFAOYSA-N 0.000 claims description 2
- NELHQWBZKJRQAS-UHFFFAOYSA-N 4-[2-(4-cyclohexylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(=CC=3)C3CCCCC3)SC=2)=C1SC NELHQWBZKJRQAS-UHFFFAOYSA-N 0.000 claims description 2
- ANLZCROUCBPHBW-UHFFFAOYSA-N 4-[2-(4-methylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(C)=CC=3)SC=2)=C1SC ANLZCROUCBPHBW-UHFFFAOYSA-N 0.000 claims description 2
- YODCXSDDGBHEEN-UHFFFAOYSA-N 4-[2-[(4-methylphenyl)methylamino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NCC=3C=CC(C)=CC=3)SC=2)=C1SC YODCXSDDGBHEEN-UHFFFAOYSA-N 0.000 claims description 2
- CXXUGGXVBJBHDR-UHFFFAOYSA-N 4-[2-[(7-bromo-9h-fluoren-2-yl)amino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C4C(C5=CC=C(Br)C=C5C4)=CC=3)SC=2)=C1SC CXXUGGXVBJBHDR-UHFFFAOYSA-N 0.000 claims description 2
- YPPRLGGJPQLBFP-UHFFFAOYSA-N 4-[2-[3-[(3-methylpiperidin-1-yl)methyl]anilino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C(CN4CC(C)CCC4)C=CC=3)SC=2)=C1SC YPPRLGGJPQLBFP-UHFFFAOYSA-N 0.000 claims description 2
- ONJMNFUCIIFBMG-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C3OCOC3=CC=2)=C1SC ONJMNFUCIIFBMG-UHFFFAOYSA-N 0.000 claims description 2
- AIWKHFBIXRNZBT-UHFFFAOYSA-N 4-[4-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC=C(OC)C(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 AIWKHFBIXRNZBT-UHFFFAOYSA-N 0.000 claims description 2
- GARVNVZOSLSGOA-UHFFFAOYSA-N 4-[4-(2-chloropyridin-3-yl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=NC=CC=2)Cl)=C1SC GARVNVZOSLSGOA-UHFFFAOYSA-N 0.000 claims description 2
- ABKSWDBOGMATIE-UHFFFAOYSA-N 4-[4-(2-hydroxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)O)=C1SC ABKSWDBOGMATIE-UHFFFAOYSA-N 0.000 claims description 2
- VPNNTFDQKJOHAQ-UHFFFAOYSA-N 4-[4-(2-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC=CC=C1C1=CSC(C2=C(SC(=C2)C(N)=N)SC)=N1 VPNNTFDQKJOHAQ-UHFFFAOYSA-N 0.000 claims description 2
- DMRSHSWYVATHJS-UHFFFAOYSA-N 4-[4-(2-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)C)=C1SC DMRSHSWYVATHJS-UHFFFAOYSA-N 0.000 claims description 2
- CJSCCQLEHSPLCW-UHFFFAOYSA-N 4-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(Cl)C(Cl)=CC=2)=C1SC CJSCCQLEHSPLCW-UHFFFAOYSA-N 0.000 claims description 2
- OAYNZGLTLILARC-UHFFFAOYSA-N 4-[4-(3,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC(OC)=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 OAYNZGLTLILARC-UHFFFAOYSA-N 0.000 claims description 2
- BAGRENDRQWTDGR-UHFFFAOYSA-N 4-[4-(3-bromophenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(Br)C=CC=2)=C1SC BAGRENDRQWTDGR-UHFFFAOYSA-N 0.000 claims description 2
- HHVBHAXDQFDPSD-UHFFFAOYSA-N 4-[4-(3-hydroxy-4-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound C1=C(O)C(OC)=CC=C1C1=CSC(C2=C(SC(=C2)C(N)=N)SC)=N1 HHVBHAXDQFDPSD-UHFFFAOYSA-N 0.000 claims description 2
- MEKFQRDWXPJRHC-UHFFFAOYSA-N 4-[4-(3-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C)C=CC=2)=C1SC MEKFQRDWXPJRHC-UHFFFAOYSA-N 0.000 claims description 2
- QCNAOMPLQHHHTO-UHFFFAOYSA-N 4-[4-(4-chloro-3-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C)C(Cl)=CC=2)=C1SC QCNAOMPLQHHHTO-UHFFFAOYSA-N 0.000 claims description 2
- KIGJPKCRBSBFNE-UHFFFAOYSA-N 4-[4-(4-chloro-3-nitrophenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C(Cl)=CC=2)[N+]([O-])=O)=C1SC KIGJPKCRBSBFNE-UHFFFAOYSA-N 0.000 claims description 2
- FLKQFRKNGNJBNP-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(C2=C(SC(=C2)C(N)=N)SC)=N1 FLKQFRKNGNJBNP-UHFFFAOYSA-N 0.000 claims description 2
- VLUCTQXBQVXUNP-UHFFFAOYSA-N 4-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(C)=CC=2)=C1SC VLUCTQXBQVXUNP-UHFFFAOYSA-N 0.000 claims description 2
- VPVMUEAKVSMETO-UHFFFAOYSA-N 4-[4-[3,5-bis(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C1SC VPVMUEAKVSMETO-UHFFFAOYSA-N 0.000 claims description 2
- OUNVWHFQDMXKLY-UHFFFAOYSA-N 4-[4-[3-fluoro-5-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C=C(F)C=2)C(F)(F)F)=C1SC OUNVWHFQDMXKLY-UHFFFAOYSA-N 0.000 claims description 2
- RMXKAJHQDHWTJX-UHFFFAOYSA-N 5-methyl-4-[2-(3,4,5-trimethoxyanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC=C(N=2)C2=C(SC(=C2)C(N)=N)C)=C1 RMXKAJHQDHWTJX-UHFFFAOYSA-N 0.000 claims description 2
- BPTSLRVJHZVZJK-UHFFFAOYSA-N 5-methyl-4-[2-(4-phenoxyanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(OC=4C=CC=CC=4)=CC=3)SC=2)=C1C BPTSLRVJHZVZJK-UHFFFAOYSA-N 0.000 claims description 2
- CKYREKXNBZFCFF-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-naphthalen-2-yl-1,3-thiazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C3C=CC=CC3=CC=2)=C1SC CKYREKXNBZFCFF-UHFFFAOYSA-N 0.000 claims description 2
- BMYJQBBNGNWLMS-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-phenyl-1,3-oxazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2OC=C(N=2)C=2C=CC=CC=2)=C1SC BMYJQBBNGNWLMS-UHFFFAOYSA-N 0.000 claims description 2
- PUHIWYRNPCRYHR-UHFFFAOYSA-N 5-methylsulfanyl-4-(5-phenylpyridin-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=CC(=CC=2)C=2C=CC=CC=2)=C1SC PUHIWYRNPCRYHR-UHFFFAOYSA-N 0.000 claims description 2
- CUQLUXBWHFUDGN-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(2-morpholin-4-ylethylamino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NCCN3CCOCC3)SC=2)=C1SC CUQLUXBWHFUDGN-UHFFFAOYSA-N 0.000 claims description 2
- OFOUKZPHGSBBIX-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(2-piperidin-2-ylethylamino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NCCC3NCCCC3)SC=2)=C1SC OFOUKZPHGSBBIX-UHFFFAOYSA-N 0.000 claims description 2
- VPPXWZPISZIDSK-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(4-phenyldiazenylanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(=CC=3)N=NC=3C=CC=CC=3)SC=2)=C1SC VPPXWZPISZIDSK-UHFFFAOYSA-N 0.000 claims description 2
- OEAWMSORVLNKJG-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(4-piperidin-1-ylsulfonylanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide;5-methylsulfanyl-4-[2-(quinolin-3-ylamino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C4C=CC=CC4=NC=3)SC=2)=C1SC.S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(=CC=3)S(=O)(=O)N3CCCCC3)SC=2)=C1SC OEAWMSORVLNKJG-UHFFFAOYSA-N 0.000 claims description 2
- FXXBRXARHYHTSQ-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(1,2-oxazol-5-yl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2ON=CC=2)=C1SC FXXBRXARHYHTSQ-UHFFFAOYSA-N 0.000 claims description 2
- YJSXRDXBOOLGGT-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(4-phenylphenyl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)=C1SC YJSXRDXBOOLGGT-UHFFFAOYSA-N 0.000 claims description 2
- WFUWFCPVIJPOGN-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(phenoxymethyl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(COC=3C=CC=CC=3)N=2)=C1SC WFUWFCPVIJPOGN-UHFFFAOYSA-N 0.000 claims description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 2
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 206010063837 Reperfusion injury Diseases 0.000 claims description 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims description 2
- 108090001109 Thermolysin Proteins 0.000 claims description 2
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims description 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims description 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 2
- 125000005422 alkyl sulfonamido group Chemical group 0.000 claims description 2
- 125000005421 aryl sulfonamido group Chemical group 0.000 claims description 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims description 2
- 125000004188 dichlorophenyl group Chemical group 0.000 claims description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims description 2
- 238000007918 intramuscular administration Methods 0.000 claims description 2
- 238000007912 intraperitoneal administration Methods 0.000 claims description 2
- 238000001990 intravenous administration Methods 0.000 claims description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 230000009826 neoplastic cell growth Effects 0.000 claims description 2
- 238000007911 parenteral administration Methods 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 238000007920 subcutaneous administration Methods 0.000 claims description 2
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 15
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 12
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 6
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 4
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 4
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 3
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 3
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 claims 3
- YMEHWISYYMKMFO-WOMRJYOTSA-N methyl N-[(12E,15S)-15-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate Chemical group COC(=O)Nc1ccc2-c3cnc([nH]3)[C@H](C\C=C\CCC(=O)Nc2c1)N1CC[C@@H](CC1=O)c1cccc(Cl)c1 YMEHWISYYMKMFO-WOMRJYOTSA-N 0.000 claims 3
- 125000000565 sulfonamide group Chemical group 0.000 claims 3
- 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 claims 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- FDRDCAYYXVHESU-UHFFFAOYSA-N 4-[2-(3-methoxyanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC=CC(NC=2SC=C(N=2)C2=C(SC(=C2)C(N)=N)SC)=C1 FDRDCAYYXVHESU-UHFFFAOYSA-N 0.000 claims 2
- KSJUFIPSZGIVLF-UHFFFAOYSA-N 4-[2-(4-chloro-2-methylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC(Cl)=CC=3)C)SC=2)=C1SC KSJUFIPSZGIVLF-UHFFFAOYSA-N 0.000 claims 2
- IQHIAMAAHJGYDK-UHFFFAOYSA-N 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C3OCCOC3=CC=2)=C1SC IQHIAMAAHJGYDK-UHFFFAOYSA-N 0.000 claims 2
- HFUGBKCICWUZIJ-UHFFFAOYSA-N 4-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 HFUGBKCICWUZIJ-UHFFFAOYSA-N 0.000 claims 2
- 125000005914 C6-C14 aryloxy group Chemical group 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 claims 1
- 125000004845 (C1-C6) alkylsulfonylamino group Chemical group 0.000 claims 1
- PTHLPYKPCQLAOF-UHFFFAOYSA-N 2,4-difluorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(F)C=C1F PTHLPYKPCQLAOF-UHFFFAOYSA-N 0.000 claims 1
- WSYQJNPRQUFCGL-UHFFFAOYSA-N 3-chlorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(Cl)=C1 WSYQJNPRQUFCGL-UHFFFAOYSA-N 0.000 claims 1
- QPXOEZUECRCZMU-UHFFFAOYSA-N 4-(2-amino-1,3-thiazol-4-yl)-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(N)SC=2)=C1SC QPXOEZUECRCZMU-UHFFFAOYSA-N 0.000 claims 1
- KGIRAOPPKLQWOI-UHFFFAOYSA-N 4-[2-(2,5-dichloroanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=C(Cl)C=3)Cl)SC=2)=C1SC KGIRAOPPKLQWOI-UHFFFAOYSA-N 0.000 claims 1
- XWCRFOTXRYVUDS-UHFFFAOYSA-N 4-[2-(2,5-dimethoxyanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC=C(OC)C(NC=2SC=C(N=2)C2=C(SC(=C2)C(N)=N)SC)=C1 XWCRFOTXRYVUDS-UHFFFAOYSA-N 0.000 claims 1
- XVPMAUVOZSXQSE-UHFFFAOYSA-N 4-[2-(2,6-dichloroanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C(=CC=CC=3Cl)Cl)SC=2)=C1SC XVPMAUVOZSXQSE-UHFFFAOYSA-N 0.000 claims 1
- MUJFCLDCVTWHPO-UHFFFAOYSA-N 4-[2-(4-benzylanilino)-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(CC=4C=CC=CC=4)=CC=3)SC=2)=C1SC MUJFCLDCVTWHPO-UHFFFAOYSA-N 0.000 claims 1
- GUFHYHFVXWKWLW-UHFFFAOYSA-N 4-[2-[3-(hydroxymethyl)anilino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C(CO)C=CC=3)SC=2)=C1SC GUFHYHFVXWKWLW-UHFFFAOYSA-N 0.000 claims 1
- HCHPQQFILQKXKI-UHFFFAOYSA-N 4-[2-[4-(4-chlorophenoxy)anilino]-1,3-thiazol-4-yl]-5-methylsulfanylthiophene-2-carboximidamide;5-methylsulfanyl-4-[2-(4-phenoxyanilino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(OC=4C=CC=CC=4)=CC=3)SC=2)=C1SC.S1C(C(N)=N)=CC(C=2N=C(NC=3C=CC(OC=4C=CC(Cl)=CC=4)=CC=3)SC=2)=C1SC HCHPQQFILQKXKI-UHFFFAOYSA-N 0.000 claims 1
- OUPJOWDHCXNNFZ-UHFFFAOYSA-N 4-[4-(2,4-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound COC1=CC(OC)=CC=C1C1=CSC(C2=C(SC(=C2)C(N)=N)SC)=N1 OUPJOWDHCXNNFZ-UHFFFAOYSA-N 0.000 claims 1
- QGSDCVGMOUWGJT-UHFFFAOYSA-N 4-[4-(2-chloropyridin-4-yl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(Cl)N=CC=2)=C1SC QGSDCVGMOUWGJT-UHFFFAOYSA-N 0.000 claims 1
- ACDXWXNJVVSKDT-UHFFFAOYSA-N 4-[4-(4-hydroxy-3-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound C1=C(O)C(OC)=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 ACDXWXNJVVSKDT-UHFFFAOYSA-N 0.000 claims 1
- LATFQEIISAOFAR-UHFFFAOYSA-N 4-[4-[3,5-bis(trifluoromethyl)phenyl]-5-methyl-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC(C)=C(N=2)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C1SC LATFQEIISAOFAR-UHFFFAOYSA-N 0.000 claims 1
- HXXGPDMZBWBAQA-UHFFFAOYSA-N 4-[4-[3-fluoro-5-(trifluoromethyl)phenyl]-5-methyl-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC(C)=C(N=2)C=2C=C(C=C(F)C=2)C(F)(F)F)=C1SC HXXGPDMZBWBAQA-UHFFFAOYSA-N 0.000 claims 1
- HHHDJHHNEURCNV-UHFFFAOYSA-N 4-chlorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Cl)C=C1 HHHDJHHNEURCNV-UHFFFAOYSA-N 0.000 claims 1
- LFLSATHZMYYIAQ-UHFFFAOYSA-N 4-flourobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(F)C=C1 LFLSATHZMYYIAQ-UHFFFAOYSA-N 0.000 claims 1
- ICYPEZDQCNHNTK-UHFFFAOYSA-N 5-methylsulfanyl-4-(5-phenyl-1,3-oxazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2OC(=CN=2)C=2C=CC=CC=2)=C1SC ICYPEZDQCNHNTK-UHFFFAOYSA-N 0.000 claims 1
- DMUUBSPLUMYPEH-UHFFFAOYSA-N 5-methylsulfanyl-4-(5-phenyl-1h-imidazol-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2NC=C(N=2)C=2C=CC=CC=2)=C1SC DMUUBSPLUMYPEH-UHFFFAOYSA-N 0.000 claims 1
- NGPPMLWAYIHMPU-UHFFFAOYSA-N 5-methylsulfanyl-4-[2-(naphthalen-2-ylamino)-1,3-thiazol-4-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(NC=3C=C4C=CC=CC4=CC=3)SC=2)=C1SC NGPPMLWAYIHMPU-UHFFFAOYSA-N 0.000 claims 1
- XSCYUONGRGZQTF-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(trifluoromethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OC(F)(F)F)C=CC=2)=C1SC XSCYUONGRGZQTF-UHFFFAOYSA-N 0.000 claims 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims 1
- 102000004173 Cathepsin G Human genes 0.000 claims 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims 1
- 125000004421 aryl sulphonamide group Chemical group 0.000 claims 1
- OVIZSQRQYWEGON-UHFFFAOYSA-N butane-1-sulfonamide Chemical compound CCCCS(N)(=O)=O OVIZSQRQYWEGON-UHFFFAOYSA-N 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims 1
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 claims 1
- SJMCLWCCNYAWRQ-UHFFFAOYSA-N propane-2-sulfonamide Chemical compound CC(C)S(N)(=O)=O SJMCLWCCNYAWRQ-UHFFFAOYSA-N 0.000 claims 1
- 229930192474 thiophene Natural products 0.000 claims 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000543 intermediate Substances 0.000 abstract description 9
- 239000003112 inhibitor Substances 0.000 abstract description 8
- 230000003389 potentiating effect Effects 0.000 abstract description 6
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 108010036927 trypsin-like serine protease Proteins 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 260
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 240
- 239000000243 solution Substances 0.000 description 138
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 136
- 230000015572 biosynthetic process Effects 0.000 description 128
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 124
- 238000003786 synthesis reaction Methods 0.000 description 121
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 120
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 102
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 84
- 238000005160 1H NMR spectroscopy Methods 0.000 description 74
- 238000001819 mass spectrum Methods 0.000 description 74
- 239000000377 silicon dioxide Substances 0.000 description 65
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 61
- 239000002904 solvent Substances 0.000 description 61
- 239000002253 acid Substances 0.000 description 59
- FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 52
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 50
- 150000001409 amidines Chemical class 0.000 description 48
- 238000006243 chemical reaction Methods 0.000 description 45
- 239000003153 chemical reaction reagent Substances 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 44
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 44
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 37
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 35
- 239000002585 base Substances 0.000 description 35
- 239000011347 resin Substances 0.000 description 31
- 229920005989 resin Polymers 0.000 description 31
- 239000007858 starting material Substances 0.000 description 28
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 27
- 150000001412 amines Chemical class 0.000 description 27
- 239000012043 crude product Substances 0.000 description 27
- 239000011159 matrix material Substances 0.000 description 27
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 25
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical class [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 24
- JKTNTKXMUOHDTM-UHFFFAOYSA-N CS[S+]1C(C(N)=N)=CC=C1.Cl Chemical compound CS[S+]1C(C(N)=N)=CC=C1.Cl JKTNTKXMUOHDTM-UHFFFAOYSA-N 0.000 description 23
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 23
- 239000011541 reaction mixture Substances 0.000 description 22
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 21
- 235000011054 acetic acid Nutrition 0.000 description 20
- 125000004432 carbon atom Chemical group C* 0.000 description 20
- WSDDCFXENOCBKW-UHFFFAOYSA-N o-methyl 4-carbamothioyl-5-methylthiophene-2-carbothioate Chemical compound COC(=S)C1=CC(C(N)=S)=C(C)S1 WSDDCFXENOCBKW-UHFFFAOYSA-N 0.000 description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 19
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 17
- 229910052794 bromium Inorganic materials 0.000 description 17
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 16
- 239000002002 slurry Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 15
- 239000011521 glass Substances 0.000 description 15
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 15
- 239000012299 nitrogen atmosphere Substances 0.000 description 15
- LWMBWXNZUVQKNS-UHFFFAOYSA-N 2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetic acid Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(O)=O)C=CC=2)=C1SC LWMBWXNZUVQKNS-UHFFFAOYSA-N 0.000 description 14
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 14
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 14
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 150000001408 amides Chemical class 0.000 description 13
- 235000019439 ethyl acetate Nutrition 0.000 description 13
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 12
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 229910052740 iodine Inorganic materials 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- QSELGEUCFNFITD-UHFFFAOYSA-N thiophene-2-carboximidamide Chemical compound NC(=N)C1=CC=CS1 QSELGEUCFNFITD-UHFFFAOYSA-N 0.000 description 12
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 229910021529 ammonia Inorganic materials 0.000 description 10
- 150000002576 ketones Chemical class 0.000 description 10
- 125000006239 protecting group Chemical group 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 9
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- AYHBDPZWHIBECB-UHFFFAOYSA-N 2-[3-[2-[5-[[(2-methylpropan-2-yl)oxycarbonylhydrazinylidene]methyl]-2-methylsulfanylthiophen-3-yl]-1,3-thiazol-4-yl]phenoxy]acetic acid Chemical compound S1C(C=NNC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(OCC(O)=O)C=CC=2)=C1SC AYHBDPZWHIBECB-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- 102100025975 Cathepsin G Human genes 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- ZPBFCHCCUASVEP-UHFFFAOYSA-N o-methyl thiophene-2-carbothioate Chemical compound COC(=S)C1=CC=CS1 ZPBFCHCCUASVEP-UHFFFAOYSA-N 0.000 description 8
- 230000017854 proteolysis Effects 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- 108010022999 Serine Proteases Proteins 0.000 description 7
- 102000012479 Serine Proteases Human genes 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
- 239000003638 chemical reducing agent Substances 0.000 description 7
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- QPFXURKQIOKXGR-UHFFFAOYSA-N s-methyl thiophene-2-carbothioate Chemical compound CSC(=O)C1=CC=CS1 QPFXURKQIOKXGR-UHFFFAOYSA-N 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 230000029936 alkylation Effects 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 6
- 230000033115 angiogenesis Effects 0.000 description 6
- 150000001450 anions Chemical class 0.000 description 6
- 210000002469 basement membrane Anatomy 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000002744 extracellular matrix Anatomy 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 6
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 230000011514 reflex Effects 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 150000003557 thiazoles Chemical class 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 239000003875 Wang resin Substances 0.000 description 5
- NERFNHBZJXXFGY-UHFFFAOYSA-N [4-[(4-methylphenyl)methoxy]phenyl]methanol Chemical compound C1=CC(C)=CC=C1COC1=CC=C(CO)C=C1 NERFNHBZJXXFGY-UHFFFAOYSA-N 0.000 description 5
- 239000002168 alkylating agent Substances 0.000 description 5
- 229940100198 alkylating agent Drugs 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 125000005605 benzo group Chemical group 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 229910000024 caesium carbonate Inorganic materials 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000003880 polar aprotic solvent Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 5
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 4
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 4
- IAZKYHCKLQOVOT-UHFFFAOYSA-N 3-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.CSC=1C=CSC=1C(N)=N IAZKYHCKLQOVOT-UHFFFAOYSA-N 0.000 description 4
- 101150041968 CDC13 gene Proteins 0.000 description 4
- SHBQDCAXABENRJ-UHFFFAOYSA-N CS[S+]1C(C(N)=N)=CC=C1 Chemical compound CS[S+]1C(C(N)=N)=CC=C1 SHBQDCAXABENRJ-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- 101001116926 Homo sapiens Protocadherin alpha-7 Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 102000013566 Plasminogen Human genes 0.000 description 4
- 108010051456 Plasminogen Proteins 0.000 description 4
- 102000001938 Plasminogen Activators Human genes 0.000 description 4
- 108010001014 Plasminogen Activators Proteins 0.000 description 4
- 102100024275 Protocadherin alpha-7 Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 125000001246 bromo group Chemical group Br* 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- XXTZHYXQVWRADW-UHFFFAOYSA-N diazomethanone Chemical compound [N]N=C=O XXTZHYXQVWRADW-UHFFFAOYSA-N 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000003948 formamides Chemical class 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 229940127126 plasminogen activator Drugs 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000012746 preparative thin layer chromatography Methods 0.000 description 4
- 239000000651 prodrug Substances 0.000 description 4
- 229940002612 prodrug Drugs 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- QERYCTSHXKAMIS-UHFFFAOYSA-M thiophene-2-carboxylate Chemical compound [O-]C(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-M 0.000 description 4
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-DYCDLGHISA-N trifluoroacetic acid-d1 Chemical compound [2H]OC(=O)C(F)(F)F DTQVDTLACAAQTR-DYCDLGHISA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- IEPSGFQQGKPTPM-UHFFFAOYSA-N 2-bromo-1-(3-hydroxyphenyl)ethanone Chemical compound OC1=CC=CC(C(=O)CBr)=C1 IEPSGFQQGKPTPM-UHFFFAOYSA-N 0.000 description 3
- UHWNENCHFSDZQP-UHFFFAOYSA-N 2-bromo-1-thiophen-2-ylethanone Chemical compound BrCC(=O)C1=CC=CS1 UHWNENCHFSDZQP-UHFFFAOYSA-N 0.000 description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 3
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 3
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- LXFJBRAKNBXJSA-UHFFFAOYSA-O COC(C1=CC(C(N)=S)=CS1)=[S+]C Chemical compound COC(C1=CC(C(N)=S)=CS1)=[S+]C LXFJBRAKNBXJSA-UHFFFAOYSA-O 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 108010006035 Metalloproteases Proteins 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- FZRKAZHKEDOPNN-UHFFFAOYSA-N Nitric oxide anion Chemical compound O=[N-] FZRKAZHKEDOPNN-UHFFFAOYSA-N 0.000 description 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 3
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 206010038923 Retinopathy Diseases 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000001772 anti-angiogenic effect Effects 0.000 description 3
- 230000002456 anti-arthritic effect Effects 0.000 description 3
- 230000001740 anti-invasion Effects 0.000 description 3
- 230000002001 anti-metastasis Effects 0.000 description 3
- 230000003262 anti-osteoporosis Effects 0.000 description 3
- 230000002769 anti-restenotic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002306 biochemical method Methods 0.000 description 3
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- MOIPGXQKZSZOQX-UHFFFAOYSA-N carbonyl bromide Chemical class BrC(Br)=O MOIPGXQKZSZOQX-UHFFFAOYSA-N 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- KWTSZCJMWHGPOS-UHFFFAOYSA-M chloro(trimethyl)stannane Chemical compound C[Sn](C)(C)Cl KWTSZCJMWHGPOS-UHFFFAOYSA-M 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000003433 contraceptive agent Substances 0.000 description 3
- 230000002254 contraceptive effect Effects 0.000 description 3
- 229940113088 dimethylacetamide Drugs 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 150000002540 isothiocyanates Chemical class 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- RBKABIGIOIHJEO-UHFFFAOYSA-N methyl 4-carbamothioyl-5-methylsulfanylthiophene-2-carboxylate Chemical compound COC(=O)C1=CC(C(N)=S)=C(SC)S1 RBKABIGIOIHJEO-UHFFFAOYSA-N 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 3
- 239000012038 nucleophile Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 3
- 229910000080 stannane Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 150000003871 sulfonates Chemical class 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- YBGZHKNEYNBBPT-UHFFFAOYSA-N tert-butyl n-[[4-[4-(3-hydroxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophen-2-yl]iminomethyl]carbamate Chemical compound S1C(N=CNC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(O)C=CC=2)=C1SC YBGZHKNEYNBBPT-UHFFFAOYSA-N 0.000 description 3
- 150000003556 thioamides Chemical class 0.000 description 3
- 150000003585 thioureas Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000002753 trypsin inhibitor Substances 0.000 description 3
- 230000002229 tumoristatic effect Effects 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- ZJIFDEVVTPEXDL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) hydrogen carbonate Chemical compound OC(=O)ON1C(=O)CCC1=O ZJIFDEVVTPEXDL-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- QBXCVQVFPVXAGS-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-2-bromoethanone Chemical compound BrCC(=O)C1=CC=C2OCOC2=C1 QBXCVQVFPVXAGS-UHFFFAOYSA-N 0.000 description 2
- BSXPDVKSFWQFRT-UHFFFAOYSA-N 1-hydroxytriazolo[4,5-b]pyridine Chemical compound C1=CC=C2N(O)N=NC2=N1 BSXPDVKSFWQFRT-UHFFFAOYSA-N 0.000 description 2
- WYJOVVXUZNRJQY-UHFFFAOYSA-N 2-Acetylthiophene Chemical compound CC(=O)C1=CC=CS1 WYJOVVXUZNRJQY-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- NUAIPKMBWNVQIM-UHFFFAOYSA-N 2-bromo-1-(3,4-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C=C1OC NUAIPKMBWNVQIM-UHFFFAOYSA-N 0.000 description 2
- IOOHBIFQNQQUFI-UHFFFAOYSA-N 2-bromo-1-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(C(=O)CBr)=C1 IOOHBIFQNQQUFI-UHFFFAOYSA-N 0.000 description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 2
- FQPKWIVFFMOKIP-UHFFFAOYSA-N 3-methylsulfanylthiophene-2-carboximidamide Chemical compound CSC=1C=CSC=1C(N)=N FQPKWIVFFMOKIP-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- HIPYFVFSCZEZBO-UHFFFAOYSA-N 4-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 HIPYFVFSCZEZBO-UHFFFAOYSA-N 0.000 description 2
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- XKVUYEYANWFIJX-UHFFFAOYSA-N 5-methyl-1h-pyrazole Chemical compound CC1=CC=NN1 XKVUYEYANWFIJX-UHFFFAOYSA-N 0.000 description 2
- DKZZZQJGLBQGOW-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-phenyl-1,3-thiazol-2-yl)thiophene-2-carbonitrile Chemical compound S1C(C#N)=CC(C=2SC=C(N=2)C=2C=CC=CC=2)=C1SC DKZZZQJGLBQGOW-UHFFFAOYSA-N 0.000 description 2
- MJHFIWGNUFBIEW-UHFFFAOYSA-N 5-methylsulfanyl-4-(4-phenyl-1,3-thiazol-2-yl)thiophene-2-carboxamide Chemical compound S1C(C(N)=O)=CC(C=2SC=C(N=2)C=2C=CC=CC=2)=C1SC MJHFIWGNUFBIEW-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 2
- 125000006847 BOC protecting group Chemical group 0.000 description 2
- DLRMHKZXFJXMMA-UHFFFAOYSA-O COC([S+]=C(C1=C(SC)SC=C1)N)=O Chemical compound COC([S+]=C(C1=C(SC)SC=C1)N)=O DLRMHKZXFJXMMA-UHFFFAOYSA-O 0.000 description 2
- KPDLDQBUGVZMJI-UHFFFAOYSA-N CS[S+]1C(C(N)=N)=CC(C2=CC(C3=CC=CC=C3)=CC=C2)=C1 Chemical compound CS[S+]1C(C(N)=N)=CC(C2=CC(C3=CC=CC=C3)=CC=C2)=C1 KPDLDQBUGVZMJI-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 229940123583 Factor Xa inhibitor Drugs 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010018364 Glomerulonephritis Diseases 0.000 description 2
- 229910004373 HOAc Inorganic materials 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 241001024304 Mino Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 2
- 208000034827 Neointima Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 102100024078 Plasma serine protease inhibitor Human genes 0.000 description 2
- 101710183733 Plasma serine protease inhibitor Proteins 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229940122388 Thrombin inhibitor Drugs 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 159000000021 acetate salts Chemical class 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- IQZLUWLMQNGTIW-UHFFFAOYSA-N acetoveratrone Chemical compound COC1=CC=C(C(C)=O)C=C1OC IQZLUWLMQNGTIW-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000005085 alkoxycarbonylalkoxy group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- ACBQROXDOHKANW-UHFFFAOYSA-N bis(4-nitrophenyl) carbonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ACBQROXDOHKANW-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- YSHOWEKUVWPFNR-UHFFFAOYSA-N burgess reagent Chemical compound CC[N+](CC)(CC)S(=O)(=O)N=C([O-])OC YSHOWEKUVWPFNR-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 230000037012 chymotrypsin-like activity Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000000224 granular leucocyte Anatomy 0.000 description 2
- 208000037824 growth disorder Diseases 0.000 description 2
- 230000010005 growth-factor like effect Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005283 haloketone group Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 150000002690 malonic acid derivatives Chemical class 0.000 description 2
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
- WMRPEKPAVMWJGD-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(2-phenyl-1,3-thiazol-4-yl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2N=C(SC=2)C=2C=CC=CC=2)=C1SC WMRPEKPAVMWJGD-UHFFFAOYSA-N 0.000 description 2
- GWRHZIJMIMABHH-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(4-naphthalen-2-yl-1,3-thiazol-2-yl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2SC=C(N=2)C=2C=C3C=CC=CC3=CC=2)=C1SC GWRHZIJMIMABHH-UHFFFAOYSA-N 0.000 description 2
- IMQPHSGNZGVGMI-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(4-phenyl-1,3-thiazol-2-yl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2SC=C(N=2)C=2C=CC=CC=2)=C1SC IMQPHSGNZGVGMI-UHFFFAOYSA-N 0.000 description 2
- PWFZZGZCVPXEBC-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(4-thiophen-2-yl-1,3-thiazol-2-yl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2SC=C(N=2)C=2SC=CC=2)=C1SC PWFZZGZCVPXEBC-UHFFFAOYSA-N 0.000 description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000008692 neointimal formation Effects 0.000 description 2
- BVOCPVIXARZNQN-UHFFFAOYSA-N nipecotamide Chemical compound NC(=O)C1CCCNC1 BVOCPVIXARZNQN-UHFFFAOYSA-N 0.000 description 2
- COMNODDXGXYQIL-UHFFFAOYSA-N o-methyl 4-(4-cyclohexyl-1,3-thiazol-2-yl)-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C2CCCCC2)=C1C COMNODDXGXYQIL-UHFFFAOYSA-N 0.000 description 2
- HRBJDQXDQIPSIJ-UHFFFAOYSA-N o-methyl 4-(6-bromopyridin-2-yl)-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2N=C(Br)C=CC=2)=C1C HRBJDQXDQIPSIJ-UHFFFAOYSA-N 0.000 description 2
- CCDJIXDKCGXMJB-UHFFFAOYSA-N o-methyl 4-[4-(2,4-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=CC(OC)=CC=2)OC)=C1C CCDJIXDKCGXMJB-UHFFFAOYSA-N 0.000 description 2
- LROVCYWRVCWWGD-UHFFFAOYSA-N o-methyl 4-[4-(2-chloro-4,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=CC(OC)=C(OC)C=2)Cl)=C1C LROVCYWRVCWWGD-UHFFFAOYSA-N 0.000 description 2
- BCKMBZNAKXNGLR-UHFFFAOYSA-N o-methyl 4-[4-(2-chloropyridin-3-yl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=NC=CC=2)Cl)=C1C BCKMBZNAKXNGLR-UHFFFAOYSA-N 0.000 description 2
- GXMWBWSAGIYHRU-UHFFFAOYSA-N o-methyl 4-[4-(2-chloropyridin-4-yl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(Cl)N=CC=2)=C1C GXMWBWSAGIYHRU-UHFFFAOYSA-N 0.000 description 2
- FLBRFJCVZSVCRK-UHFFFAOYSA-N o-methyl 4-[4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(OC)C(OC)=CC=2)=C1C FLBRFJCVZSVCRK-UHFFFAOYSA-N 0.000 description 2
- LFOWREILRCOVDO-UHFFFAOYSA-N o-methyl 4-[4-(3,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(OC)C=C(OC)C=2)=C1C LFOWREILRCOVDO-UHFFFAOYSA-N 0.000 description 2
- LMEVRMIUKWSYCA-UHFFFAOYSA-N o-methyl 4-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(OC)C=CC=2)=C1C LMEVRMIUKWSYCA-UHFFFAOYSA-N 0.000 description 2
- JOIFZKXEJUNUNS-UHFFFAOYSA-N o-methyl 4-[4-(4-chloropyridin-3-yl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=CC=NC=2)Cl)=C1C JOIFZKXEJUNUNS-UHFFFAOYSA-N 0.000 description 2
- JZZGWIDASGZUAY-UHFFFAOYSA-N o-methyl 5-methyl-4-[4-(2-methylphenyl)-1,3-thiazol-2-yl]thiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)C)=C1C JZZGWIDASGZUAY-UHFFFAOYSA-N 0.000 description 2
- PGIHUCCENURQAA-UHFFFAOYSA-N o-methyl 5-methyl-4-trimethylstannylthiophene-2-carbothioate Chemical compound COC(=S)C1=CC([Sn](C)(C)C)=C(C)S1 PGIHUCCENURQAA-UHFFFAOYSA-N 0.000 description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 238000013146 percutaneous coronary intervention Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxy-acetic acid Natural products OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 102200145332 rs111033190 Human genes 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 210000004722 stifle Anatomy 0.000 description 2
- 230000006103 sulfonylation Effects 0.000 description 2
- 238000005694 sulfonylation reaction Methods 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- NHAAWCGOTKQSSU-UHFFFAOYSA-N tert-butyl 2-[2-[2-[5-[[(2-methylpropan-2-yl)oxycarbonylhydrazinylidene]methyl]-2-methylsulfanylthiophen-3-yl]-1,3-thiazol-4-yl]phenoxy]acetate Chemical compound S1C(C=NNC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)OCC(=O)OC(C)(C)C)=C1SC NHAAWCGOTKQSSU-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- URAGJMBGNVOIJC-UHFFFAOYSA-N thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CS1 URAGJMBGNVOIJC-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
- 230000007838 tissue remodeling Effects 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000007995 vascular wound healing Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DIVNUTGTTIRPQA-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1OC DIVNUTGTTIRPQA-UHFFFAOYSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- BIWOSRSKDCZIFM-RXMQYKEDSA-N (3r)-piperidin-3-ol Chemical compound O[C@@H]1CCCNC1 BIWOSRSKDCZIFM-RXMQYKEDSA-N 0.000 description 1
- JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical compound O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- DAXJNUBSBFUTRP-RTQNCGMRSA-N (8r,9s,10r,13s,14s)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(CO)C2=C1 DAXJNUBSBFUTRP-RTQNCGMRSA-N 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- CHPRFKYDQRKRRK-LURJTMIESA-N (S)-2-(methoxymethyl)pyrrolidine Chemical compound COC[C@@H]1CCCN1 CHPRFKYDQRKRRK-LURJTMIESA-N 0.000 description 1
- POTIYWUALSJREP-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline Chemical compound N1CCCC2CCCCC21 POTIYWUALSJREP-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- HBCUGAOVQVFKTD-UHFFFAOYSA-N 1-[2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetyl]piperidine-3-carboxamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CC(CCC3)C(N)=O)C=CC=2)=C1SC HBCUGAOVQVFKTD-UHFFFAOYSA-N 0.000 description 1
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 1
- USYQKCQEVBFJRP-UHFFFAOYSA-N 1-bromo-3-phenylbenzene Chemical compound BrC1=CC=CC(C=2C=CC=CC=2)=C1 USYQKCQEVBFJRP-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- WGMHMVLZFAJNOT-UHFFFAOYSA-N 1-ethoxyethylideneazanium;chloride Chemical compound [Cl-].CCOC(C)=[NH2+] WGMHMVLZFAJNOT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- PKDPUENCROCRCH-UHFFFAOYSA-N 1-piperazin-1-ylethanone Chemical compound CC(=O)N1CCNCC1 PKDPUENCROCRCH-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- RBZRMBCLZMEYEH-UHFFFAOYSA-N 1h-pyrazol-1-ium-1-carboximidamide;chloride Chemical compound Cl.NC(=N)N1C=CC=N1 RBZRMBCLZMEYEH-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- KBVDUUXRXJTAJC-UHFFFAOYSA-N 2,5-dibromothiophene Chemical compound BrC1=CC=C(Br)S1 KBVDUUXRXJTAJC-UHFFFAOYSA-N 0.000 description 1
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 1
- ZNJRONVKWRHYBF-UHFFFAOYSA-N 2-[2-[2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-yl)ethenyl]-6-methylpyran-4-ylidene]propanedinitrile Chemical compound O1C(C)=CC(=C(C#N)C#N)C=C1C=CC1=CC(CCCN2CCC3)=C2C3=C1 ZNJRONVKWRHYBF-UHFFFAOYSA-N 0.000 description 1
- MVPQCQBLTQSRFB-UHFFFAOYSA-N 2-[2-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetic acid Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)OCC(O)=O)=C1SC MVPQCQBLTQSRFB-UHFFFAOYSA-N 0.000 description 1
- PYGBFRKSRJYZPB-UHFFFAOYSA-N 2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]-n-(2-morpholin-4-ylethyl)acetamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NCCN3CCOCC3)C=CC=2)=C1SC PYGBFRKSRJYZPB-UHFFFAOYSA-N 0.000 description 1
- RVMZUNBBDWBPQR-UHFFFAOYSA-N 2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]-n-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NC=3C=4CCCCC=4C=CC=3)C=CC=2)=C1SC RVMZUNBBDWBPQR-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- CSSHRKYOZTZFCX-UHFFFAOYSA-N 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone Chemical compound O1CCOC2=CC(C(=O)CBr)=CC=C21 CSSHRKYOZTZFCX-UHFFFAOYSA-N 0.000 description 1
- PKVBZABQCCQHLD-UHFFFAOYSA-N 2-bromo-1-(2,4-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C(OC)=C1 PKVBZABQCCQHLD-UHFFFAOYSA-N 0.000 description 1
- RGQNFYVSEWDUEI-UHFFFAOYSA-N 2-bromo-1-(2,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(OC)C(C(=O)CBr)=C1 RGQNFYVSEWDUEI-UHFFFAOYSA-N 0.000 description 1
- VFEAXQQGIBFGRX-UHFFFAOYSA-N 2-bromo-1-(2-chloro-4,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(Cl)=C(C(=O)CBr)C=C1OC VFEAXQQGIBFGRX-UHFFFAOYSA-N 0.000 description 1
- CDPOPLQSBPBLCR-UHFFFAOYSA-N 2-bromo-1-(2-chloropyridin-3-yl)ethanone Chemical compound ClC1=NC=CC=C1C(=O)CBr CDPOPLQSBPBLCR-UHFFFAOYSA-N 0.000 description 1
- BZWBRLWSWBQIBX-UHFFFAOYSA-N 2-bromo-1-(2-chloropyridin-4-yl)ethanone Chemical compound ClC1=CC(C(=O)CBr)=CC=N1 BZWBRLWSWBQIBX-UHFFFAOYSA-N 0.000 description 1
- GKNCPTLOPRDYMH-UHFFFAOYSA-N 2-bromo-1-(2-methoxyphenyl)ethanone Chemical compound COC1=CC=CC=C1C(=O)CBr GKNCPTLOPRDYMH-UHFFFAOYSA-N 0.000 description 1
- XMGAXELQRATLJP-UHFFFAOYSA-N 2-bromo-1-(2-methylphenyl)ethanone Chemical compound CC1=CC=CC=C1C(=O)CBr XMGAXELQRATLJP-UHFFFAOYSA-N 0.000 description 1
- PAKFHEFMTRCFAU-UHFFFAOYSA-N 2-bromo-1-(3,4-dichlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C=C1Cl PAKFHEFMTRCFAU-UHFFFAOYSA-N 0.000 description 1
- JUJBYPJUERJZQP-UHFFFAOYSA-N 2-bromo-1-(3,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(OC)=CC(C(=O)CBr)=C1 JUJBYPJUERJZQP-UHFFFAOYSA-N 0.000 description 1
- MZBXSQBQPJWECM-UHFFFAOYSA-N 2-bromo-1-(3-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=CC(Br)=C1 MZBXSQBQPJWECM-UHFFFAOYSA-N 0.000 description 1
- BANFRNTVKCHZDE-UHFFFAOYSA-N 2-bromo-1-(3-methylphenyl)ethanone Chemical compound CC1=CC=CC(C(=O)CBr)=C1 BANFRNTVKCHZDE-UHFFFAOYSA-N 0.000 description 1
- LUCPZLPBUCDKQE-UHFFFAOYSA-N 2-bromo-1-(4-chloro-3-methylphenyl)ethanone Chemical compound CC1=CC(C(=O)CBr)=CC=C1Cl LUCPZLPBUCDKQE-UHFFFAOYSA-N 0.000 description 1
- FXNQTMRPLLNPQY-UHFFFAOYSA-N 2-bromo-1-(4-chloro-3-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC(C(=O)CBr)=CC=C1Cl FXNQTMRPLLNPQY-UHFFFAOYSA-N 0.000 description 1
- KIBALZNTVRKLIQ-UHFFFAOYSA-N 2-bromo-1-(4-chloropyridin-3-yl)ethanone Chemical compound ClC1=CC=NC=C1C(=O)CBr KIBALZNTVRKLIQ-UHFFFAOYSA-N 0.000 description 1
- XQJAHBHCLXUGEP-UHFFFAOYSA-N 2-bromo-1-(4-methoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C=C1 XQJAHBHCLXUGEP-UHFFFAOYSA-N 0.000 description 1
- KRVGXFREOJHJAX-UHFFFAOYSA-N 2-bromo-1-(4-methylphenyl)ethanone Chemical compound CC1=CC=C(C(=O)CBr)C=C1 KRVGXFREOJHJAX-UHFFFAOYSA-N 0.000 description 1
- MBUPVGIGAMCMBT-UHFFFAOYSA-N 2-bromo-1-(4-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=C(C(=O)CBr)C=C1 MBUPVGIGAMCMBT-UHFFFAOYSA-N 0.000 description 1
- KGHGZRVXCKCJGX-UHFFFAOYSA-N 2-bromo-1-(4-phenylphenyl)ethanone Chemical compound C1=CC(C(=O)CBr)=CC=C1C1=CC=CC=C1 KGHGZRVXCKCJGX-UHFFFAOYSA-N 0.000 description 1
- WZNSNVNABYKOAU-UHFFFAOYSA-N 2-bromo-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethanone Chemical compound C1CCCC2=CC(C(=O)CBr)=CC=C21 WZNSNVNABYKOAU-UHFFFAOYSA-N 0.000 description 1
- ADLIDZNESKOPIP-UHFFFAOYSA-N 2-bromo-1-cyclohexylethanone Chemical compound BrCC(=O)C1CCCCC1 ADLIDZNESKOPIP-UHFFFAOYSA-N 0.000 description 1
- YHXHHGDUANVQHE-UHFFFAOYSA-N 2-bromo-1-naphthalen-2-ylethanone Chemical compound C1=CC=CC2=CC(C(=O)CBr)=CC=C21 YHXHHGDUANVQHE-UHFFFAOYSA-N 0.000 description 1
- WPDWOCRJBPXJFM-UHFFFAOYSA-N 2-bromo-1-phenylpropan-1-one Chemical compound CC(Br)C(=O)C1=CC=CC=C1 WPDWOCRJBPXJFM-UHFFFAOYSA-N 0.000 description 1
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- MONMFXREYOKQTI-UHFFFAOYSA-N 2-bromopropanoic acid Chemical compound CC(Br)C(O)=O MONMFXREYOKQTI-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- RXTRRIFWCJEMEL-UHFFFAOYSA-N 2-chloropyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1Cl RXTRRIFWCJEMEL-UHFFFAOYSA-N 0.000 description 1
- NPRZWOJTSGFSBF-UHFFFAOYSA-N 2-chloropyridine-4-carbonyl chloride Chemical compound ClC(=O)C1=CC=NC(Cl)=C1 NPRZWOJTSGFSBF-UHFFFAOYSA-N 0.000 description 1
- QBBKKFZGCDJDQK-UHFFFAOYSA-N 2-ethylpiperidine Chemical compound CCC1CCCCN1 QBBKKFZGCDJDQK-UHFFFAOYSA-N 0.000 description 1
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- 125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000006088 2-oxoazepinyl group Chemical group 0.000 description 1
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
- 125000006087 2-oxopyrrolodinyl group Chemical group 0.000 description 1
- UJXIOVIFPTXDHU-UHFFFAOYSA-N 2-phenylethanethioyl chloride Chemical compound ClC(=S)CC1=CC=CC=C1 UJXIOVIFPTXDHU-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WZHHYIOUKQNLQM-UHFFFAOYSA-N 3,4,5,6-tetrachlorophthalic acid Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(O)=O WZHHYIOUKQNLQM-UHFFFAOYSA-N 0.000 description 1
- YJLVXRPNNDKMMO-UHFFFAOYSA-N 3,4,5,6-tetrafluorophthalic acid Chemical compound OC(=O)C1=C(F)C(F)=C(F)C(F)=C1C(O)=O YJLVXRPNNDKMMO-UHFFFAOYSA-N 0.000 description 1
- BMHMKWXYXFBWMI-UHFFFAOYSA-N 3,4-Methylenedioxyacetophenone Chemical compound CC(=O)C1=CC=C2OCOC2=C1 BMHMKWXYXFBWMI-UHFFFAOYSA-N 0.000 description 1
- MNOJRWOWILAHAV-UHFFFAOYSA-N 3-bromophenol Chemical compound OC1=CC=CC(Br)=C1 MNOJRWOWILAHAV-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- ZRXHLJNBNWVNIM-UHFFFAOYSA-N 3-methyl-1-benzofuran Chemical compound C1=CC=C2C(C)=COC2=C1 ZRXHLJNBNWVNIM-UHFFFAOYSA-N 0.000 description 1
- JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 description 1
- YPCQGXROGPCKMD-UHFFFAOYSA-N 4-[4-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.COC1=CC=C(OC)C(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 YPCQGXROGPCKMD-UHFFFAOYSA-N 0.000 description 1
- YCFCTSQXRKIRRI-UHFFFAOYSA-N 4-[4-(2-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C(=CC=CC=2)C)=C1SC YCFCTSQXRKIRRI-UHFFFAOYSA-N 0.000 description 1
- SUBPTCLVSUWMGL-UHFFFAOYSA-N 4-[4-(3,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.COC1=CC(OC)=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 SUBPTCLVSUWMGL-UHFFFAOYSA-N 0.000 description 1
- QQEXMGBNJLPRCL-UHFFFAOYSA-N 4-[4-(3-hydroxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(O)C=CC=2)=C1SC QQEXMGBNJLPRCL-UHFFFAOYSA-N 0.000 description 1
- VBUYALKQEZGLBD-UHFFFAOYSA-N 4-[4-(3-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C)C=CC=2)=C1SC VBUYALKQEZGLBD-UHFFFAOYSA-N 0.000 description 1
- QOIVCSLYFPCXMW-UHFFFAOYSA-N 4-[4-(4-chloro-3-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(C)C(Cl)=CC=2)=C1SC QOIVCSLYFPCXMW-UHFFFAOYSA-N 0.000 description 1
- UYIJZIKDZYEPJT-UHFFFAOYSA-N 4-[4-(4-chloro-3-nitrophenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioic S-acid Chemical compound S1C(C(S)=O)=CC(C=2SC=C(N=2)C=2C=C(C(Cl)=CC=2)[N+]([O-])=O)=C1C UYIJZIKDZYEPJT-UHFFFAOYSA-N 0.000 description 1
- ITQQDKUANLIWBF-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C1=CSC(C2=C(SC(=C2)C(N)=N)SC)=N1 ITQQDKUANLIWBF-UHFFFAOYSA-N 0.000 description 1
- PFXRQNSVWLOSRE-UHFFFAOYSA-N 4-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(C)=CC=2)=C1SC PFXRQNSVWLOSRE-UHFFFAOYSA-N 0.000 description 1
- ZMICVAPSGQLRQO-UHFFFAOYSA-N 4-[4-[3-[2-(3,4,4a,5,6,7,8,8a-octahydro-2h-quinolin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3C4CCCCC4CCC3)C=CC=2)=C1SC ZMICVAPSGQLRQO-UHFFFAOYSA-N 0.000 description 1
- KXERBTQOKJTZHA-UHFFFAOYSA-N 4-[4-[3-[2-(3,4,4a,5,6,7,8,8a-octahydro-2h-quinolin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3C4CCCCC4CCC3)C=CC=2)=C1SC KXERBTQOKJTZHA-UHFFFAOYSA-N 0.000 description 1
- DPFAWSNLFDHHEM-UHFFFAOYSA-N 4-[4-[3-[2-(3,4-dihydro-2h-quinolin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3C4=CC=CC=C4CCC3)C=CC=2)=C1SC DPFAWSNLFDHHEM-UHFFFAOYSA-N 0.000 description 1
- SKIORZFVJPYQCM-UHFFFAOYSA-N 4-[4-[3-[2-(4-acetylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(CC3)C(C)=O)C=CC=2)=C1SC SKIORZFVJPYQCM-UHFFFAOYSA-N 0.000 description 1
- MWSFXHVOKIZKTC-UHFFFAOYSA-N 4-[4-[3-[2-(4-benzylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(CC=4C=CC=CC=4)CC3)C=CC=2)=C1SC MWSFXHVOKIZKTC-UHFFFAOYSA-N 0.000 description 1
- SEUPWPBHPUISDJ-UHFFFAOYSA-N 4-[4-[3-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(C)CC3)C=CC=2)=C1SC SEUPWPBHPUISDJ-UHFFFAOYSA-N 0.000 description 1
- OKAZLQDVGKUHBN-UHFFFAOYSA-N 4-[4-[3-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(C)CC3)C=CC=2)=C1SC OKAZLQDVGKUHBN-UHFFFAOYSA-N 0.000 description 1
- XKFKUOZMCOCLFL-UHFFFAOYSA-M 4-[4-[3-[2-(4-methylpiperidin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-1-methylsulfanylthiophen-1-ium-2-carboximidamide 2,2,2-trifluoroacetate Chemical compound CC(CC1)CCN1C(COC1=CC=CC(C2=CSC(C(C=C3C(N)=N)=C[S+]3SC)=N2)=C1)=O.[O-]C(C(F)(F)F)=O XKFKUOZMCOCLFL-UHFFFAOYSA-M 0.000 description 1
- DPLPWWDZXHHZJJ-UHFFFAOYSA-N 4-[4-[3-[2-(4-methylpiperidin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCC(C)CC3)C=CC=2)=C1SC DPLPWWDZXHHZJJ-UHFFFAOYSA-N 0.000 description 1
- YHTPTJMAJSJPIU-VEIFNGETSA-N 4-[4-[3-[2-[(2r)-2-(anilinomethyl)pyrrolidin-1-yl]-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3[C@H](CCC3)CNC=3C=CC=CC=3)C=CC=2)=C1SC YHTPTJMAJSJPIU-VEIFNGETSA-N 0.000 description 1
- IZYLZWJWSXWHDD-CQSZACIVSA-N 4-[4-[3-[2-[(3r)-3-(methoxymethyl)pyrrolidin-1-yl]-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound C1[C@H](COC)CCN1C(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 IZYLZWJWSXWHDD-CQSZACIVSA-N 0.000 description 1
- XOLMCPSTEAZYQL-PFEQFJNWSA-N 4-[4-[3-[2-[(3r)-3-(methoxymethyl)pyrrolidin-1-yl]-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@H](COC)CCN1C(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 XOLMCPSTEAZYQL-PFEQFJNWSA-N 0.000 description 1
- DJNQJSIMWWYNNO-CQSZACIVSA-N 4-[4-[3-[2-[(3r)-3-hydroxypiperidin-1-yl]-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3C[C@H](O)CCC3)C=CC=2)=C1SC DJNQJSIMWWYNNO-CQSZACIVSA-N 0.000 description 1
- LMGNVDVVSANYDA-ZDUSSCGKSA-N 4-[4-[3-[2-[(3s)-3-hydroxypyrrolidin-1-yl]-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3C[C@@H](O)CC3)C=CC=2)=C1SC LMGNVDVVSANYDA-ZDUSSCGKSA-N 0.000 description 1
- ABGXADJDTPFFSZ-UHFFFAOYSA-N 4-benzylpiperidine Chemical compound C=1C=CC=CC=1CC1CCNCC1 ABGXADJDTPFFSZ-UHFFFAOYSA-N 0.000 description 1
- XGVYCMDLKFHDEW-UHFFFAOYSA-N 4-bromo-5-methylthiophene-2-carbothioic s-acid Chemical compound CC=1SC(C(S)=O)=CC=1Br XGVYCMDLKFHDEW-UHFFFAOYSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- 125000005986 4-piperidonyl group Chemical group 0.000 description 1
- 125000002471 4H-quinolizinyl group Chemical group C=1(C=CCN2C=CC=CC12)* 0.000 description 1
- SODWJACROGQSMM-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalen-1-amine Chemical compound C1CCCC2=C1C=CC=C2N SODWJACROGQSMM-UHFFFAOYSA-N 0.000 description 1
- CTDXVKWJDOIDEU-UHFFFAOYSA-N 5-methoxycarbonyl-2-methylthiophene-3-carbothioic s-acid Chemical compound COC(=O)C1=CC(C(S)=O)=C(C)S1 CTDXVKWJDOIDEU-UHFFFAOYSA-N 0.000 description 1
- KQWBHCKDMTXDLL-UHFFFAOYSA-N 5-methyl-4-[4-(3-methylphenyl)-1,3-thiazol-2-yl]thiophene-2-carbothioic S-acid Chemical compound S1C(C(S)=O)=CC(C=2SC=C(N=2)C=2C=C(C)C=CC=2)=C1C KQWBHCKDMTXDLL-UHFFFAOYSA-N 0.000 description 1
- SWKVUKUMYSNAGI-UHFFFAOYSA-N 5-methyl-4-[4-(4-methylphenyl)-1,3-thiazol-2-yl]thiophene-2-carbothioic S-acid Chemical compound S1C(C(S)=O)=CC(C=2SC=C(N=2)C=2C=CC(C)=CC=2)=C1C SWKVUKUMYSNAGI-UHFFFAOYSA-N 0.000 description 1
- GDERVCXRALFKIF-UHFFFAOYSA-N 5-methylsulfanyl-4-(2-phenyl-1,3-thiazol-4-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(SC=2)C=2C=CC=CC=2)=C1SC GDERVCXRALFKIF-UHFFFAOYSA-N 0.000 description 1
- QJBLOXHRGXCQHF-UHFFFAOYSA-N 5-methylsulfanyl-4-(6-phenylpyridin-2-yl)thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2N=C(C=CC=2)C=2C=CC=CC=2)=C1SC QJBLOXHRGXCQHF-UHFFFAOYSA-N 0.000 description 1
- LMCNGJXAPBJWFG-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1SC LMCNGJXAPBJWFG-UHFFFAOYSA-N 0.000 description 1
- QJMHWUGFNIOSOL-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]thiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1SC QJMHWUGFNIOSOL-UHFFFAOYSA-N 0.000 description 1
- TVQSONUSFKVUHY-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(4-phenylphenyl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)=C1SC TVQSONUSFKVUHY-UHFFFAOYSA-N 0.000 description 1
- UTRAESCQZNIYJN-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-thiazol-2-yl]thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C3CCCCC3=CC=2)=C1SC UTRAESCQZNIYJN-UHFFFAOYSA-N 0.000 description 1
- KQPFZBRRERCBOK-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(2-morpholin-4-yl-2-oxoethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCOCC3)C=CC=2)=C1SC KQPFZBRRERCBOK-UHFFFAOYSA-N 0.000 description 1
- LJGKCEKXSSAUAU-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(2-morpholin-4-yl-2-oxoethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCOCC3)C=CC=2)=C1SC LJGKCEKXSSAUAU-UHFFFAOYSA-N 0.000 description 1
- GLRYKBFDFQIVCK-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(2-oxo-2-piperazin-1-ylethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCNCC3)C=CC=2)=C1SC GLRYKBFDFQIVCK-UHFFFAOYSA-N 0.000 description 1
- CAOUNMQTSDMRMS-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(2-oxo-2-piperazin-1-ylethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide 2,2,2-trifluoroacetic acid Chemical compound FC(C(=O)O)(F)F.CSC1=C(C=C(S1)C(=N)N)C=1SC=C(N1)C1=CC(=CC=C1)OCC(N1CCNCC1)=O CAOUNMQTSDMRMS-UHFFFAOYSA-N 0.000 description 1
- IFTXEUWQYOJUJP-UHFFFAOYSA-N 5-methylsulfanyl-4-[4-[3-(2-oxo-2-pyrrolidin-1-ylethoxy)phenyl]-1,3-thiazol-2-yl]thiophene-2-carboximidamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCCC3)C=CC=2)=C1SC IFTXEUWQYOJUJP-UHFFFAOYSA-N 0.000 description 1
- AXSQTCBARFBKPH-UHFFFAOYSA-N 5-methylsulfanylthiophene-2-carboximidamide Chemical compound CSC1=CC=C(C(N)=N)S1 AXSQTCBARFBKPH-UHFFFAOYSA-N 0.000 description 1
- NSMWZPQRAJMQQP-UHFFFAOYSA-N 5-methylthiophene-2-carbothioic s-acid Chemical compound CC1=CC=C(C(S)=O)S1 NSMWZPQRAJMQQP-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100173726 Arabidopsis thaliana OR23 gene Proteins 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910015845 BBr3 Inorganic materials 0.000 description 1
- ZAYVBSAELMQQRJ-UHFFFAOYSA-N BrC1=CC=C[S+]1Br Chemical compound BrC1=CC=C[S+]1Br ZAYVBSAELMQQRJ-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- FSDHPEVAFMYGCW-UHFFFAOYSA-O CC(C)(C)OC(NC(NC(OC(C)(C)C)=O)=[S+]C)=O Chemical compound CC(C)(C)OC(NC(NC(OC(C)(C)C)=O)=[S+]C)=O FSDHPEVAFMYGCW-UHFFFAOYSA-O 0.000 description 1
- ZFBQUBHBNFEGDP-UHFFFAOYSA-N CC(C)S(C1=C(C)SC(C(OC)=S)=C1)(=O)=O.CS[S+]1C(C(N)=N)=CC=C1 Chemical compound CC(C)S(C1=C(C)SC(C(OC)=S)=C1)(=O)=O.CS[S+]1C(C(N)=N)=CC=C1 ZFBQUBHBNFEGDP-UHFFFAOYSA-N 0.000 description 1
- MHILKMNDBWHACQ-UHFFFAOYSA-N COC(C1=CC(C(CBr)=O)=CS1)=[S+]C Chemical compound COC(C1=CC(C(CBr)=O)=CS1)=[S+]C MHILKMNDBWHACQ-UHFFFAOYSA-N 0.000 description 1
- YXYSBPGGWXUDES-UHFFFAOYSA-N COC(C1=CC(C2=NC(C3=CC=CS3)=CS2)=C[S+]1SC)=O Chemical compound COC(C1=CC(C2=NC(C3=CC=CS3)=CS2)=C[S+]1SC)=O YXYSBPGGWXUDES-UHFFFAOYSA-N 0.000 description 1
- HTLNDGBOTXYPIB-UHFFFAOYSA-N COC(C1=CC([Sn](C)(C)C)=CS1)=[S+]C Chemical compound COC(C1=CC([Sn](C)(C)C)=CS1)=[S+]C HTLNDGBOTXYPIB-UHFFFAOYSA-N 0.000 description 1
- IBTPRYMYCUEQNP-UHFFFAOYSA-N COC(C=C1NC2=NC(C(C=C3C(N)=N)=C[S+]3SC)=CS2)=CC=C1OC Chemical compound COC(C=C1NC2=NC(C(C=C3C(N)=N)=C[S+]3SC)=CS2)=CC=C1OC IBTPRYMYCUEQNP-UHFFFAOYSA-N 0.000 description 1
- HACRYEYFCQKBJO-UHFFFAOYSA-N CSC(SC(C(N)=N)=C1)=C1C1=NC(C2=CC=CC=C2)=C[S+]1C1=CC=CC=C1 Chemical compound CSC(SC(C(N)=N)=C1)=C1C1=NC(C2=CC=CC=C2)=C[S+]1C1=CC=CC=C1 HACRYEYFCQKBJO-UHFFFAOYSA-N 0.000 description 1
- VVNXXJLXBSJZCE-UHFFFAOYSA-N CSC([S+](C=C1)C(N)=N)=C1C1=NC(C2=CC=CC(OCC([O-])=O)=C2)=CS1 Chemical compound CSC([S+](C=C1)C(N)=N)=C1C1=NC(C2=CC=CC(OCC([O-])=O)=C2)=CS1 VVNXXJLXBSJZCE-UHFFFAOYSA-N 0.000 description 1
- DPXYPDHPYNQYTI-UHFFFAOYSA-N CS[S+]1C(C(N)=N)=CC(C2=NC(C3=CC=CC=C3)=CS2)=C1.Cl Chemical compound CS[S+]1C(C(N)=N)=CC(C2=NC(C3=CC=CC=C3)=CS2)=C1.Cl DPXYPDHPYNQYTI-UHFFFAOYSA-N 0.000 description 1
- IQVLRKNPPOHMAP-UHFFFAOYSA-N CS[S+]1C(C(N)=N)=CC(C2=NC(C3CCCCC3)=CS2)=C1 Chemical compound CS[S+]1C(C(N)=N)=CC(C2=NC(C3CCCCC3)=CS2)=C1 IQVLRKNPPOHMAP-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- 108090000227 Chymases Proteins 0.000 description 1
- 102000003858 Chymases Human genes 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
- 102000012545 EGF-like domains Human genes 0.000 description 1
- 108050002150 EGF-like domains Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229910004039 HBF4 Inorganic materials 0.000 description 1
- 238000006846 Hantzsch Thiazole synthesis reaction Methods 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000933179 Homo sapiens Cathepsin G Proteins 0.000 description 1
- 101000851058 Homo sapiens Neutrophil elastase Proteins 0.000 description 1
- 101100448208 Human herpesvirus 6B (strain Z29) U69 gene Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical group N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- QECVIPBZOPUTRD-UHFFFAOYSA-N N=S(=O)=O Chemical group N=S(=O)=O QECVIPBZOPUTRD-UHFFFAOYSA-N 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 238000003482 Pinner synthesis reaction Methods 0.000 description 1
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
- 102000004179 Plasminogen Activator Inhibitor 2 Human genes 0.000 description 1
- 108090000614 Plasminogen Activator Inhibitor 2 Proteins 0.000 description 1
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QGPSKWIQTSXASS-UHFFFAOYSA-N S1C(C(=N)NC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(C)CC3)C=CC=2)=C1SC Chemical compound S1C(C(=N)NC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(C)CC3)C=CC=2)=C1SC QGPSKWIQTSXASS-UHFFFAOYSA-N 0.000 description 1
- 102000002255 Secretory Proteinase Inhibitory Proteins Human genes 0.000 description 1
- 108010000303 Secretory Proteinase Inhibitory Proteins Proteins 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 101710187074 Serine proteinase inhibitor Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000006859 Swern oxidation reaction Methods 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 101710097834 Thiol protease Proteins 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- RFUGMORVSDZBLC-UHFFFAOYSA-N [Na].CC(N)=O Chemical compound [Na].CC(N)=O RFUGMORVSDZBLC-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- AZMSATIZTOBUCU-UHFFFAOYSA-N acetic acid;5-methylsulfanyl-4-(4-thiophen-2-yl-1,3-thiazol-2-yl)thiophene-2-carboximidamide Chemical compound CC(O)=O.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2SC=CC=2)=C1SC AZMSATIZTOBUCU-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 125000004947 alkyl aryl amino group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000005239 aroylamino group Chemical group 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000004467 aryl imino group Chemical group 0.000 description 1
- 229910052789 astatine Inorganic materials 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- NRBUVVTTYMTSKM-UHFFFAOYSA-N benzyl n-[phenylmethoxycarbonylamino(pyrazol-1-yl)methylidene]carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC(N1N=CC=C1)=NC(=O)OCC1=CC=CC=C1 NRBUVVTTYMTSKM-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-N bromoacetic acid Chemical compound OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102220408281 c.161G>T Human genes 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- VQXINLNPICQTLR-UHFFFAOYSA-N carbonyl diazide Chemical compound [N-]=[N+]=NC(=O)N=[N+]=[N-] VQXINLNPICQTLR-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002711 cysteinyl group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 229940042397 direct acting antivirals cyclic amines Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 230000032692 embryo implantation Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- YFXCNIVBAVFOBX-UHFFFAOYSA-N ethenylboronic acid Chemical compound OB(O)C=C YFXCNIVBAVFOBX-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- XGQWWKOVVXYTLU-UHFFFAOYSA-N ethyl 1-[2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetyl]piperidine-3-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1C(C(=O)OCC)CCCN1C(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 XGQWWKOVVXYTLU-UHFFFAOYSA-N 0.000 description 1
- KUGMXEIVPFZGFQ-UHFFFAOYSA-N ethyl 1-[2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 KUGMXEIVPFZGFQ-UHFFFAOYSA-N 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- SZIKRGHFZTYTIT-UHFFFAOYSA-N ethyl piperidine-2-carboxylate Chemical compound CCOC(=O)C1CCCCN1 SZIKRGHFZTYTIT-UHFFFAOYSA-N 0.000 description 1
- XIWBSOUNZWSFKU-UHFFFAOYSA-N ethyl piperidine-3-carboxylate Chemical compound CCOC(=O)C1CCCNC1 XIWBSOUNZWSFKU-UHFFFAOYSA-N 0.000 description 1
- RUJPPJYDHHAEEK-UHFFFAOYSA-N ethyl piperidine-4-carboxylate Chemical compound CCOC(=O)C1CCNCC1 RUJPPJYDHHAEEK-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- QEWYKACRFQMRMB-UHFFFAOYSA-M fluoroacetate Chemical compound [O-]C(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-M 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 102000052896 human CTSG Human genes 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 150000004797 ketoamides Chemical class 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 239000003591 leukocyte elastase inhibitor Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- JORQDGTZGKHEEO-UHFFFAOYSA-N lithium cyanide Chemical compound [Li+].N#[C-] JORQDGTZGKHEEO-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- XKXULTKFSXJAIH-UHFFFAOYSA-N methyl 2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(=C2)C(N)=N)SC)=C1 XKXULTKFSXJAIH-UHFFFAOYSA-N 0.000 description 1
- DQELRSADUKZFDW-UHFFFAOYSA-N methyl 2-[3-[2-[5-[[(2-methylpropan-2-yl)oxycarbonylhydrazinylidene]methyl]-2-methylsulfanylthiophen-3-yl]-1,3-thiazol-4-yl]phenoxy]acetate Chemical compound COC(=O)COC1=CC=CC(C=2N=C(SC=2)C2=C(SC(C=NNC(=O)OC(C)(C)C)=C2)SC)=C1 DQELRSADUKZFDW-UHFFFAOYSA-N 0.000 description 1
- RDMSDMSSVFMCKQ-UHFFFAOYSA-N methyl 4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2C=CC=CC=2)=C1C(F)(F)F RDMSDMSSVFMCKQ-UHFFFAOYSA-N 0.000 description 1
- FZWCFJUONBGATQ-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(3-phenylphenyl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2C=C(C=CC=2)C=2C=CC=CC=2)=C1SC FZWCFJUONBGATQ-UHFFFAOYSA-N 0.000 description 1
- JIHYLLMIZBAXFF-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-(6-phenylpyridin-2-yl)thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2N=C(C=CC=2)C=2C=CC=CC=2)=C1SC JIHYLLMIZBAXFF-UHFFFAOYSA-N 0.000 description 1
- HMWVUDHXGPVMTD-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-[4-(4-phenylphenyl)-1,3-thiazol-2-yl]thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2SC=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)=C1SC HMWVUDHXGPVMTD-UHFFFAOYSA-N 0.000 description 1
- PVYGCJDHHGVEKL-UHFFFAOYSA-N methyl 5-methylsulfanyl-4-[4-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-thiazol-2-yl]thiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=CC(C=2SC=C(N=2)C=2C=C3CCCCC3=CC=2)=C1SC PVYGCJDHHGVEKL-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- OCIDXARMXNJACB-UHFFFAOYSA-N n'-phenylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=C1 OCIDXARMXNJACB-UHFFFAOYSA-N 0.000 description 1
- KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 1
- SJYQYOVTHISIKX-UHFFFAOYSA-N n,n-dimethylformamide;n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CN(C)C=O.CCN(C(C)C)C(C)C SJYQYOVTHISIKX-UHFFFAOYSA-N 0.000 description 1
- YXRPHMVUMUKKOS-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine;pyridine Chemical compound C1=CC=NC=C1.CN(C)C1=CC=NC=C1 YXRPHMVUMUKKOS-UHFFFAOYSA-N 0.000 description 1
- NBOHFDLTXGSNEQ-UHFFFAOYSA-N n-(2-aminoethyl)-2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetamide Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NCCN)C=CC=2)=C1SC NBOHFDLTXGSNEQ-UHFFFAOYSA-N 0.000 description 1
- GTMDNSJLBFPEIF-UHFFFAOYSA-N n-(2-aminoethyl)-2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetamide;hydrochloride Chemical compound Cl.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NCCN)C=CC=2)=C1SC GTMDNSJLBFPEIF-UHFFFAOYSA-N 0.000 description 1
- BCWUSIPLYMQYES-UHFFFAOYSA-N n-(2-anilinoethyl)-2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NCCNC=3C=CC=CC=3)C=CC=2)=C1SC BCWUSIPLYMQYES-UHFFFAOYSA-N 0.000 description 1
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- XJLSEXAGTJCILF-UHFFFAOYSA-N nipecotic acid Chemical compound OC(=O)C1CCCNC1 XJLSEXAGTJCILF-UHFFFAOYSA-N 0.000 description 1
- OKXGHXHZNCJMSV-UHFFFAOYSA-N nitro phenyl carbonate Chemical compound [O-][N+](=O)OC(=O)OC1=CC=CC=C1 OKXGHXHZNCJMSV-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000009935 nitrosation Effects 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- UPRIKOWZTZCDNC-UHFFFAOYSA-N o-methyl 4-(2-bromoacetyl)-5-methylthiophene-2-carbothioate Chemical compound COC(=S)C1=CC(C(=O)CBr)=C(C)S1 UPRIKOWZTZCDNC-UHFFFAOYSA-N 0.000 description 1
- KSUQRAADFLDCHC-UHFFFAOYSA-N o-methyl 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C3OCCOC3=CC=2)=C1C KSUQRAADFLDCHC-UHFFFAOYSA-N 0.000 description 1
- XCHFUVBWKDZRCB-UHFFFAOYSA-N o-methyl 4-[4-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C(=CC=C(OC)C=2)OC)=C1C XCHFUVBWKDZRCB-UHFFFAOYSA-N 0.000 description 1
- WLOHLYFWIXDROZ-UHFFFAOYSA-N o-methyl 4-[4-(3-bromophenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(Br)C=CC=2)=C1C WLOHLYFWIXDROZ-UHFFFAOYSA-N 0.000 description 1
- CWHGETUITUOKFB-UHFFFAOYSA-N o-methyl 4-[4-(3-hydroxyphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(O)C=CC=2)=C1C CWHGETUITUOKFB-UHFFFAOYSA-N 0.000 description 1
- FDGNEGNXBGZHGV-UHFFFAOYSA-N o-methyl 4-[4-(4-chloro-3-methylphenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(C)C(Cl)=CC=2)=C1C FDGNEGNXBGZHGV-UHFFFAOYSA-N 0.000 description 1
- QXHZLMBDIYULLB-UHFFFAOYSA-N o-methyl 4-[4-(4-chloro-3-nitrophenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(C(Cl)=CC=2)[N+]([O-])=O)=C1C QXHZLMBDIYULLB-UHFFFAOYSA-N 0.000 description 1
- NWRJAGRKZONGEN-UHFFFAOYSA-N o-methyl 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-methylthiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=CC(Cl)=CC=2)=C1C NWRJAGRKZONGEN-UHFFFAOYSA-N 0.000 description 1
- UYCBCYMXRDANAV-UHFFFAOYSA-N o-methyl 5-methyl-4-[4-(3-methylphenyl)-1,3-thiazol-2-yl]thiophene-2-carbothioate Chemical compound S1C(C(=S)OC)=CC(C=2SC=C(N=2)C=2C=C(C)C=CC=2)=C1C UYCBCYMXRDANAV-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 125000005327 perimidinyl group Chemical group N1C(=NC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000005954 phenoxathiinyl group Chemical group 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- HXEACLLIILLPRG-UHFFFAOYSA-M pipecolate Chemical compound [O-]C(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-M 0.000 description 1
- VUNPWIPIOOMCPT-UHFFFAOYSA-N piperidin-3-ylmethanol Chemical compound OCC1CCCNC1 VUNPWIPIOOMCPT-UHFFFAOYSA-N 0.000 description 1
- SRJOCJYGOFTFLH-UHFFFAOYSA-M piperidine-4-carboxylate Chemical compound [O-]C(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-M 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000002806 plasmin inhibitor Substances 0.000 description 1
- 230000033885 plasminogen activation Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 150000003140 primary amides Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 102220214356 rs1060501305 Human genes 0.000 description 1
- 102220286063 rs1405786437 Human genes 0.000 description 1
- 102220095348 rs876659304 Human genes 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Chemical class 0.000 description 1
- 230000015590 smooth muscle cell migration Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- SXSPSWNDHWWOKN-UHFFFAOYSA-N tert-butyl 2-[3-[2-[5-[[(2-methylpropan-2-yl)oxycarbonylhydrazinylidene]methyl]-2-methylsulfanylthiophen-3-yl]-1,3-thiazol-4-yl]phenoxy]acetate Chemical compound S1C(C=NNC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)OC(C)(C)C)C=CC=2)=C1SC SXSPSWNDHWWOKN-UHFFFAOYSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- UJJDEOLXODWCGK-UHFFFAOYSA-N tert-butyl carbonochloridate Chemical compound CC(C)(C)OC(Cl)=O UJJDEOLXODWCGK-UHFFFAOYSA-N 0.000 description 1
- AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 1
- CNSIMXISLBKBMD-UHFFFAOYSA-N tert-butyl n-[2-[[2-[3-[2-(5-carbamimidoyl-2-methylsulfanylthiophen-3-yl)-1,3-thiazol-4-yl]phenoxy]acetyl]amino]ethyl]carbamate Chemical compound S1C(C(N)=N)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)NCCNC(=O)OC(C)(C)C)C=CC=2)=C1SC CNSIMXISLBKBMD-UHFFFAOYSA-N 0.000 description 1
- QFNFDHNZVTWZED-UHFFFAOYSA-N tert-butyl n-[[(2-methylpropan-2-yl)oxycarbonylamino]-pyrazol-1-ylmethylidene]carbamate Chemical compound CC(C)(C)OC(=O)NC(=NC(=O)OC(C)(C)C)N1C=CC=N1 QFNFDHNZVTWZED-UHFFFAOYSA-N 0.000 description 1
- QTZOZTPXTIXYBE-UHFFFAOYSA-N tert-butyl n-[[4-[4-[3-[2-(4-acetylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-thiazol-2-yl]-5-methylsulfanylthiophen-2-yl]iminomethyl]carbamate Chemical compound S1C(N=CNC(=O)OC(C)(C)C)=CC(C=2SC=C(N=2)C=2C=C(OCC(=O)N3CCN(CC3)C(C)=O)C=CC=2)=C1SC QTZOZTPXTIXYBE-UHFFFAOYSA-N 0.000 description 1
- GOQZIPJCBUYLIR-UHFFFAOYSA-N tert-butyl n-[n-[(2-methylpropan-2-yl)oxycarbonyl]-n'-(trifluoromethylsulfonyl)carbamimidoyl]carbamate Chemical compound CC(C)(C)OC(=O)NC(=NS(=O)(=O)C(F)(F)F)NC(=O)OC(C)(C)C GOQZIPJCBUYLIR-UHFFFAOYSA-N 0.000 description 1
- DQQJBEAXSOOCPG-UHFFFAOYSA-N tert-butyl n-pyrrolidin-3-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNC1 DQQJBEAXSOOCPG-UHFFFAOYSA-N 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000006090 thiamorpholinyl sulfone group Chemical group 0.000 description 1
- 125000006089 thiamorpholinyl sulfoxide group Chemical group 0.000 description 1
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
- 229940071127 thioglycolate Drugs 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- LAWUZBKFMNSOGG-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=[C]S1 LAWUZBKFMNSOGG-UHFFFAOYSA-N 0.000 description 1
- 239000003868 thrombin inhibitor Substances 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- ZWYDDDAMNQQZHD-UHFFFAOYSA-L titanium(ii) chloride Chemical compound [Cl-].[Cl-].[Ti+2] ZWYDDDAMNQQZHD-UHFFFAOYSA-L 0.000 description 1
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- REDSKZBUUUQMSK-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC.CCCC[Sn](CCCC)CCCC REDSKZBUUUQMSK-UHFFFAOYSA-N 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical group COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 108010065822 urokinase inhibitor Proteins 0.000 description 1
- 102000009816 urokinase plasminogen activator receptor activity proteins Human genes 0.000 description 1
- 108040001269 urokinase plasminogen activator receptor activity proteins Proteins 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7411098P | 1998-02-09 | 1998-02-09 | |
| US60/074,110 | 1998-02-09 | ||
| PCT/US1999/002784 WO1999040088A1 (en) | 1998-02-09 | 1999-02-09 | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2321025A1 true CA2321025A1 (en) | 1999-08-12 |
Family
ID=22117801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002321025A Abandoned CA2321025A1 (en) | 1998-02-09 | 1999-02-09 | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1054886B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002502852A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE223408T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU765072B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2321025A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69902754T2 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ506507A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999040088A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291514B1 (en) | 1998-02-09 | 2001-09-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
| EP1152759A2 (en) * | 1999-02-09 | 2001-11-14 | 3-Dimensional Pharmaceuticals, Inc. | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| PL351767A1 (en) * | 1999-02-09 | 2003-06-16 | Dimensional Pharmaceuticals 3 | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
| WO2002057273A1 (en) * | 2001-01-20 | 2002-07-25 | Trigen Limited | Serine protease inhibitors comprising a hydrogen-bond acceptor |
| AU2002242500A1 (en) * | 2001-03-02 | 2002-09-19 | Merck Frosst Canada And Co. | Cathepsin cysteine protease inhibitors |
| AU2003219039A1 (en) * | 2002-03-11 | 2003-09-22 | Curacyte Ag | Urokinase inhibitors, production and use thereof |
| UA80131C2 (en) * | 2002-05-28 | 2007-08-27 | Dimensional Pharm Inc | Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| EP1394159A1 (fr) * | 2002-08-13 | 2004-03-03 | Warner-Lambert Company LLC | Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| GB0315111D0 (en) | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
| US7482376B2 (en) | 2003-07-03 | 2009-01-27 | 3-Dimensional Pharmaceuticals, Inc. | Conjugated complement cascade inhibitors |
| BRPI0412502A (pt) * | 2003-07-10 | 2006-09-19 | Achillion Pharmaceuticals Inc | derivados de ariltiouréia substituìda úteis como inibidores de replicação viral |
| US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
| MX2007016439A (es) | 2005-06-24 | 2008-03-04 | Wilex Ag | Uso de inhibidores de urocinasa para el tratamiento y/o prevencion de enfermedades neuropatologicas. |
| PL1968973T3 (pl) * | 2005-12-27 | 2012-03-30 | Hoffmann La Roche | Pochodne aryloizoksazol-4-iloimidazolu |
| EP2017263A4 (en) | 2006-05-09 | 2011-11-30 | Daiichi Sankyo Co Ltd | Heteroarylamide derivative of a lower carboxylic acid |
| WO2008124300A1 (en) | 2007-04-10 | 2008-10-16 | National Health Research Institutes | Hepatitis c virus inhibitors |
| TW200848016A (en) | 2007-06-08 | 2008-12-16 | Nat Health Research Institutes | Thiourea compound and composition of treating hepatitis C virus infection |
| TWI361808B (en) | 2008-01-08 | 2012-04-11 | Nat Health Research Institutes | Imidazolidinone and imidazolidinethione derivatives |
| US8198284B2 (en) | 2008-04-30 | 2012-06-12 | National Health Research Institutes | Treatment of neurodegenerative disorders with thiourea compounds |
| BR112012000254A2 (pt) | 2009-07-08 | 2016-02-16 | Dermira Canada Inc | análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas. |
| CR20160136A (es) | 2013-08-28 | 2016-08-04 | Medivation Technologies Inc | Compuestos heterocíclicos |
| EP3265457A1 (en) | 2015-03-04 | 2018-01-10 | Medivation Technologies LLC | Sterol regulatory element-binding proteins (srebps) inhibitors |
| EP3265088A1 (en) | 2015-03-04 | 2018-01-10 | Medivation Technologies LLC | Srebp blockers for use in treating liver fibrosis, elevated cholesterol and insulin resistance |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4220654A (en) * | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
| US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
| GB9312761D0 (en) * | 1993-06-21 | 1993-08-04 | Wellcome Found | Amino acid derivatives |
| ATE222100T1 (de) * | 1993-10-21 | 2002-08-15 | Searle & Co | Amidino-derivate nützlich als no synthase-hemmer |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| TW414795B (en) * | 1996-07-01 | 2000-12-11 | Yamanouchi Pharma Co Ltd | A thiophene derivative and the pharmaceutical composition |
| DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
| PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
| AU2424499A (en) * | 1998-01-26 | 1999-08-09 | Basf Aktiengesellschaft | Heterocyclic amidines as callicrein protease inhibitors |
| WO1999037668A1 (de) * | 1998-01-26 | 1999-07-29 | Basf Aktiengesellschaft | Thrombininhibitoren |
-
1999
- 1999-02-09 NZ NZ506507A patent/NZ506507A/en unknown
- 1999-02-09 AU AU26665/99A patent/AU765072B2/en not_active Ceased
- 1999-02-09 JP JP2000530517A patent/JP2002502852A/ja active Pending
- 1999-02-09 AT AT99906845T patent/ATE223408T1/de not_active IP Right Cessation
- 1999-02-09 WO PCT/US1999/002784 patent/WO1999040088A1/en not_active Ceased
- 1999-02-09 DE DE69902754T patent/DE69902754T2/de not_active Expired - Lifetime
- 1999-02-09 CA CA002321025A patent/CA2321025A1/en not_active Abandoned
- 1999-02-09 EP EP99906845A patent/EP1054886B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69902754T2 (de) | 2003-08-07 |
| EP1054886B1 (en) | 2002-09-04 |
| WO1999040088A1 (en) | 1999-08-12 |
| AU765072B2 (en) | 2003-09-11 |
| AU2666599A (en) | 1999-08-23 |
| JP2002502852A (ja) | 2002-01-29 |
| ATE223408T1 (de) | 2002-09-15 |
| NZ506507A (en) | 2003-08-29 |
| EP1054886A1 (en) | 2000-11-29 |
| DE69902754D1 (de) | 2002-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6403633B2 (en) | Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors | |
| EP1054886B1 (en) | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors | |
| US6492403B1 (en) | Methods of treating C1s-mediated diseases and conditions and compositions thereof | |
| CA2437587C (en) | Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents | |
| AU2001287991B2 (en) | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases | |
| JP2002502852A5 (cg-RX-API-DMAC7.html) | ||
| WO2000047578A1 (en) | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors | |
| AU2005230867A1 (en) | Certain triazole-based compounds, compositions, and uses thereof | |
| OA10764A (en) | Protease inhibitors | |
| AU2005221134A1 (en) | Inhibitors of histone deacetylase | |
| AU2013291865A1 (en) | Thiophene derivatives used in the treatment of diabetes | |
| US9603834B2 (en) | 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |